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1 INTRODUCTION 
 
This chapter will introduce the topic of the thesis. It first starts by discussing the pharmaceuti-
cal industry and its products due to their varying nature from other consumer products. In 
what follows, the research problem as well as objectives of this study are presented along 
with the structure of the thesis. 
 
!"! #$%&'%()*+,(%-.,/0*1+&2.
 
The product lifespan of a medicine varies quite an extent from a typical consumer product. 
Firstly, introducing a new, patented drug to the market is an expensive process that can take 
nearly 12 years due to the long product development process as well as applying for commer-
cial licenses and certifications. In the end, the product may only have eight years time to be 
sold on the market before the patent expires and price competition commences. (Rafiq & 
Saxon, 2000) Thus, the industry has traditionally largely relied on strong R&D, aggressive 
sales force, and defense of patents, while branding has not been the focus. (Veloutsou & 
Panigyrakis, 2001; Moss & Schuiling, 2004; Moss, 2007). When compared to fast moving 
consumer goods (FMCG), pharmaceutical products have shorter lifespans and require particu-
lar product lifecycle management (Moss, 2007). Following, pharmaceutical companies have 
not typically focused on building centuries-lasting brands, as has been the practice in the 
FMCG industry. There has also been confusion about the concept of a brand and how it 
should be managed. 
 
The whole business strategy of pharmaceutical companies has conventionally been innovative 
and R&D-oriented, which has led to stressing the importance of few, cash cow products 
called “blockbusters”. They are patented products that are created after an extensive and ex-
pensive R&D process and alone bring significant profit to the company. (Trombetta, 2004; 
Moss, 2007)  This has also implied that the product comes before the consumer and branding 
has been rather tactical than strategic (e.g. Moss, 2007; Tebbey et al., 2009). However, intro-
ducing a new blockbuster drug to the market is becoming even more expensive as the costs of 
R&D increase and governments are looking for tightening the existing marketing (Veloutsou 
& Panigyrakis, 2001; Moss & Schuiling, 2004; Moss, 2007; Rod et al., 2007). Moreover, the 
amount of new molecular entities (NME), which the blockbusters are based on, has recently 
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decreased. Consequently, this has led to the product pipeline shrinking despite the increased 
investments in R&D (Kvesic, 2008; Dubey & Dubey, 2009). It has further resulted in looking 
for new procedures to maintain the business and therefore also postulated for new marketing 
methods in addition to migrating to a consumer-led business strategy (Moss & Schuiling, 
2004; Moss, 2007; Trombetta, 2007).  
 
To acquire new competitive advantage and answer the tough competition, Moss and Schuiling 
(2004) suggest that pharmaceutical companies should start paying more attention to building 
brands than simply products, therefore transferring from research-oriented, product-centric 
strategy to brand and consumer centricity. In addition, Moss and Schuiling (2004) as well as 
Griffiths (2007) clearly state that pharmaceutical companies ought not to solely rely on their 
sales force and R&D anymore – the emphasis needs to be put on marketing and branding. 
Veloutsou and Panigyrakis (2010) add that simply counting on price competition and personal 
selling methods is not a long-lasting strategy and not sufficient in today’s market. According 
to Blackett and Harrison (2001), there is a growing need for the pharmaceutical companies to 
learn how to construct and manage brands.  
 
Further on, the consumer behavior in the pharmaceutical market is changing. Consumers are 
becoming more aware of the variety of medicines due to the increased role of the Internet 
(e.g. Moss & Schuiling, 2004), and are demanding more information and options from their 
physicians. End users of pharmaceutical products are no longer merely patients, but rather 
educated consumers and the whole health-care industry has become consumer-driven (Mad-
dox, 1999). Concentrating on building strong, trusted brands in the corporate as well as prod-
uct level could perhaps help to cope with the tightening regulation and the above barriers, and 
act as a strategic asset for the industry suffering from low growth, diminished pipelines, ac-
celerating patent expiries, and immense pressure on prices (Moss, 2007; Moss, 2008).  
 
!"3 456)(+,7)1.
 
The objective of this study is multisided. Firstly, I am investigating a conservative, behind-
lagging industry through a window of modern consumer culture theory. Moreover, the specif-
ic theoretical framework will address a current and complex subject of utilizing corporate 
branding in product marketing. As this may seem as a great deal of various theories and work, 
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it must be noted that even corporate brands have been researched rather slightly in the phar-
maceutical market (e.g. Moss, 2007), let alone consumer-brand relationships. Namely, based 
on various articles (e.g. Moss & Schuiling, 2004; Griffiths, 2007; Moss, 2007; Tebbey et al. 
2009; Kauppinen-Räisänen et al., 2012), there is hardly any research on this topic and nearly 
all the studies I found focused on other types of consumer products such as food products. 
However, various studies (e.g. Moss, 2007) found that branding of pharmaceuticals is a rising 
trend as is building consumer attachment towards brands (Malär et al., 2011). This thesis will 
thus provide new insight into the theoretical discussion. In addition, as Moss (2007) defines, 
the pharmaceutical industry is at least 10 years behind the FMCG sector in branding. The goal 
is to bring the industry to this day by applying modern consumer theories of emotional brand-
ing and combine them with corporate branding. Therefore, I will suggestively present some 
new angles to various theories as well. 
 
The thesis will focus on investigating self-care products due to several advantages compared 
to prescription medicines. Firstly, although self-care products may also have a doctor or a 
hospital as a mediator in the buying process, it is not as significant as with prescription medi-
cines, which typically require an arbitrator and therefore create the buying process more com-
plicated. In addition, advertising of self-care products is not as restricted as it is with prescrip-
tion medicines. This way, I may also apply the consumer-brand relationship theory because 
the point of sale situation does not vary as much. In academic literature, self-care pharmaceu-
tical products are referred to as over-the-counter products, “OTC”, which is why I will use 
this term in the text. I will also use the abbreviation “POM” for prescription-only-medicines. 
 
The research was conducted in co-operation with Orion Oyj that is a Finnish pharmaceutical 
company and almost 100 years old. For Orion this will not only help to understand various 
OTC product categories’ brands and evaluate their marketing, and what these brand relation-
ships indeed denote to individual consumers, but to learn how the role of the consumer is 
changing through culture and new consumer behavior. Due to its important and strategic na-
ture, branding should be the concern of the top management. Schuiling and Moss (2004) even 
state that since there has been such an insufficient focus on brand management in pharmaceu-
tical companies, concentrating on this and mastering it could offer true competitive advantage 
and help surpassing ever-increasing challenges. Finally, the thesis will help to understand 
how the consumers experience brands and what kind of meanings brands maintain in their 
daily lives. 
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The target and purpose of this thesis is to answer to the following research question that is 
quite simplistic but outright encapsulates the whole substance of this document: 
 
Q1: How do consumers experience relationships with a pharmaceutical corporate brand and 
OTC product brands? 
 
This is to investigate the finding by various academic articles (e.g. Blackett & Harrison, 2001; 
Schuiling & Moss, 2004; Moss, 2007) that there nearly exist no strong, medical corporate 
brands and the pharmaceutical companies are seen as strangers to consumers and even to doc-
tors. As the practical purpose of this thesis is to examine to what extent the corporate brand 
should be utilized in product marketing, it is justified to first determine how consumers expe-
rience the corporate brand, especially Orion that is a long-standing and presumably renowned 
brand in Finland due to the extensive advertising as well. In addition, the emotions and expe-
riences are investigated in terms of single product brands: 
 
Q:2 What kind of experiences and emotions do consumers share with OTC brands? 
 
This is to further elaborate the first question by condescending to the actual emotional level. 
The question will thus proceed more into detail by explaining how the consumer-brand rela-
tionships are built and how they evolve during time. The third chapter of the theory will dis-
cuss consumer emotional branding, which will be the framework guiding this question. 
 
Q3: How is the consumer trust built towards the OTC products? 
 
Blackett and Harrison (2001) find trust the most important emotional value in the pharmaceu-
tical industry, which is why it is justified to study it more in order to also understand the com-
position of a brand relationship. Moreover, through loyal, trusting customers a pharmaceutical 
company could survive the price war as these consumers have higher tolerance towards pre-
mium pricing (Hess & Story, 2005). Needless to say, branding has a great impact on consum-
er trust, which validates combining the two theories of corporate and product brand relation-
ships and consumer emotional brand attachment. Through this question, I seek to explain how 
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the consumer’s trust is constructed and how brands may facilitate creating a committed and 
enduring relationship. 
 
!"< =+&*(+*&).%/0.&)1)%&($.+2:).
 
This thesis is formed by nine main chapters. Followed by the first chapter, which contained 
introduction and research objectives, a short literature review on branding will be presented, 
after which product brands and corporate brands will be thoroughly discussed along with the 
consumer emotional brand attachment building. In the fifth chapter, a synthesis of the litera-
ture review will be presented as a theoretical framework that the research will focus on. The 
literature review of this thesis has two sides: investigating the phenomenon from the view-
point of the corporation and the consumer. This is seen in first discussing the nature of corpo-
rate branding and strategies of applying it to the product level, and then introducing the con-
sumer-brand relationship typology. To begin with, the empirical part will introduce consumer 
profiles of the interviewees to explain what kind of experiences the consumers share with 
OTC brands in their history and daily lives. Secondly, larger empirical themes of trust and 
brand relationship construction are explored.  
 
The research type of this thesis is qualitative consumer interviews focusing on the consumer 
experiences and stories with the brands they prefer to explain. Due to the sensitive nature of 
the pharmaceutical products to consumers, it was justifiable to conduct personal interviews 
where the discussion could, moreover, be directed. The interviewee group was not chosen 
based on their demographic differences, but rather psychographic in terms of including spe-
cific lifestyles. Neither was the group supposed to represent the whole consumer group of 
OTC products, but to provide insight on how an individual consumer feels.  
 
 
“Eventually all pharmaceutical brands will need to behave like  
the most successful consumer-brands and that may mean taking  
a global approach to branding, through advertising and identity” 
 
Blackett & Robins (2001) 
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2 AN OVERVIEW TO BRANDING 
 
This chapter presents a brief literature review on brands to support the importance of this top-
ic. Such key concepts as brand meanings, brand associations, brand equity, and brand aware-
ness are discussed. I will also display the special characteristics of pharmaceutical and OTC 
brands. 
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Brands include both intangible and tangible benefits to the consumer, which help to differen-
tiate and therefore exceed the concept of a product. These benefits are all communicated to 
the consumer by a brand name that distinguishes the product (Schuiling & Moss, 2004). 
Brands are intangible assets, market organisms that are maintained through actions performed 
by managers and the environment (Jevons et al., 2005). Managers and consumers together 
build the meaning of the brand, which causes certain uncontrollability of brands and leaves 
only parts of the brands observable for the managers. Moreover, consumers as well as manag-
ers all have various cognitive meanings for brands, which creates managing and understand-
ing brands complex. According to Jevons et al. (2005), the altering environment of communi-
cations also creates barriers to control brand associations since Internet and other types of 
media, where consumers can share experiences, gain popularity.  
 
de Chernatony (2002) states that a brand is formed by a dynamic encounter of managers’ ac-
tions and the customer receptions. She continues to explain that brands contain two types of 
values: functional and emotional. The values aim at producing a specific experience for the 
customer, therefore creating a promised brand experience. For Orion, this type of promise 
could be an analgesic drug increasing wellbeing, also a core corporate value, through the 
functional benefit of removing the pain and the emotional value of enhancing the customer’s 
mood and providing reliability as well as quality. In the article, de Chernatony mentions that 
executing a brand successfully presumes the managers to define the core values, the staff to 
implement them, and the customers to appreciate the implemented values. 
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Jevons et al. (2005) stress the importance of paying attention to the associations perceived by 
the customers and the relationships brands have with each other in order to understand the 
meaning of brand relationships. According to de Chernatony (2002), a brand includes mean-
ings formed by the brand identity, which is created by the managers, and meanings associated 
by the users or customers. These brand associations are defined as perceptions, meanings, and 
preferences attached to the brand in one’s mind (Keller, 1993). Jevons et al. (2005) thus iden-
tify as one of the key challenges and missions of managers to narrow down the gap between 
customers and brands by harvesting proper brand associations. If successful, a brand may 
have the power of exceeding the market and even borders of countries (Blackett & Harrison, 
2001). 
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Brand values are beliefs, thoughts, and feelings consumers attach to brands and discover posi-
tively influencing their behavior, potentially leading to a purchase decision (Blackett and Har-
rison, 2001). In such, they are corner stones of building a brand; what the consumer manufac-
turer relationship is truly like. Furthermore, brand values may represent emotional or rational 
beliefs. Blackett and Harrison divide the brand values into three categories: functional, ex-
pressive, and central values. The values are constructed through various influences the con-
sumers experience – advertising, purchasing environment, packaging, brand name, brand 
logo, and personal experiences, to name but a few. Indeed, as defined in the previous section, 
the challenge of managers is to control these, typically unmanageable beliefs and seek to lead 
the brand to fulfill the consumer’s beliefs in order to influence the consumer response. 
 
The rational beliefs are much based on the perceived, functional attributes of the product; for 
example, does the pain remedy take the headache away or not. In short, the functional values 
answer the consumer’s question of “how the brand helps me?” The most important functional 
value for the pharmaceutical industry has been promoting the safety of products, which can be 
seen in such benefit as the efficacy of the product. Namely, does the product help with the 
specific condition? Or convenience; is the product easy to administer, what is the dosage form 
like? Thus, functional values are already included in the product during manufacturing. 
(Blackett & Harrison, 2001; Moss & Schuiling, 2004; Schuiling & Moss, 2004) 
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On the other hand, expressive values proceed beyond the perceived factors of the brand. They 
are non-rational, emotional values and based on the image of the brand the consumer main-
tains. Blackett and Harrison (2001) among with Schuiling and Moss (2004) define one the 
most powerful emotional value that should be harvested in the pharmaceutical field to be 
trust. According to the both articles, the pharmaceutical field has much to learn in promoting 
and appealing to consumers’ expressive values, to which the consumers may reflect. Safety, 
another key aspect in terms of medicine, was in fact discovered to be associated with higher 
priced items (Tse, 1999). It is also suggested that safety of a product will in future gain even 
more importance, therefore offering yet another, essential expressive value for the pharma-
ceutical field to utilize in branding. 
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In building a branding strategy, the most important first step is to define the brand position-
ing; what aspects of the brand represent unique, distinctive and attractive attributes to the con-
sumers that will help to differentiate the brand? These may be functional benefits; such as the 
amount of vitamin B a food supplement contains; or simply emotional, the energy that the 
vitamin brand represents and evokes in a consumer. At best, these benefits are defensible and 
unique to the consumer, which set and maintain the brand in a place different from the com-
petitors. This type of position requires the company to understand the product and needs of 
the consumers buying it. Thus, a target segment that holds an interest towards the product 
must be selected and the brand accordingly developed. Finally, the brand must be cultivated 
and refined according to the consumer responses. (Blackett & Harrison, 2001) 
 
However, according to various studies (e.g. Blackett & Harrison, 2001; Moss, 2007; Malär et 
al., 2011), positioning brands based on simply functional benefits is not enough, and the stress 
should be in emotional values. Emphasizing emotional values has not been the reality in the 
pharmaceutical industry, despite, as discussed already, the key brand value of the pharmaceu-
tical products appears to be trust. Though it might sound simple, building consumer trust is 
extremely difficult and once won, it should indeed be cherished. In addition, a pharmaceutical 
brand should represent relief and effectiveness to the consumer, otherwise trust will not be 
built. This varies quite an extent from, for example, food brands, which are composed around 
much simpler needs than relieving different types of pains, symptoms, or illnesses. Yet, few 
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pharmaceutical brands have been able to master communicating these emotional values to 
consumers. (Blackett & Harrison, 2001; Moss & Schuiling, 2004; Schuiling & Moss, 2004) 
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Brand personality facilitates the brand to differentiate and position itself as it represents the 
emotional characteristics the brand signifies to the consumer. A brand personality is devel-
oped and maintained through visual marketing and advertising of the brand, and is best ex-
plained by how the brand appears to the market audience. These visual attributes are the 
package, brand name, and advertising, through which the brand personality is built. Blackett 
and Harrison (2001) explain that though a brand name is only one part of the branding strate-
gy, it is extremely important as it has the power of associating the brand to all audiences. In 
particular, the brand name is crucial in the OTC market, which has along with the whole 
pharmaceutical industry, suffered from misleading and inefficient brand name building 
(Schuiling & Moss, 2004). 
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Brand equity represent the process where the consumer pays more for the product that con-
tains the same qualities as others, but holds a specific brand name to it (Bello & Holbrook, 
1995). Thus, brand equity represents the specific position a product maintains on the market 
place, in the consumer’s mind. Schiffman and Kanuk (1997) further define brand equity as 
the facilitator of enhanced value and also premium pricing, in a way signifying “added value” 
to the customer. According to Aaker (1991), brand equity consists of five dimensions; brand 
name awareness, perceived brand quality, brand associations, brand loyalty, and other brand 
assets such as patents and trademarks.  
 
In the pharmaceutical market, as products generally have shorter life spans, brand equity has 
not been stressed as much (Moss, 2007). According to Griffiths (2007), it is possible to build 
brand equity to medical products through increased consumer loyalty, which would eventual-
ly lead to elongated product lifecycles. This is well seen with such painkiller brands as Bura-
na and Aspirin that contain high brand equity. Though they include the same ingredients as 
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other, competing brands, consumers are willing to financially invest much in them because of 
the brand name. 
 
Elliot and Percy (2007) claim that brand equity may also be explained by the consumer 
awareness towards the brand. The awareness results in specific associations to the brand in 
the consumer’s mind, which in time evolve to emotional associations that contain more than 
simple affection towards the brand. For the awareness to result in a purchase, the associations 
need to evoke either brand recall or recognition. However, this to happen, the brand must 
have salience in the consumer’s mind (Sanyal & Datta, 2011); the associations must meet the 
consumer’s needs and arise when these needs take place (Ehrenberg et al., 1997). Brand 
awareness also increases brand dominance, which consequently leads to a more probable pur-
chase decision (Sanyal & Datta, 2011).  
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Lyon (2001) defines one of the key trends in the pharmaceutical industry the growing interest 
of consumers towards preventive self-care products and resulting growth in purchases of non-
prescription medicines. Blackett and Harrison (2001) as well as DeLorme et al. (2010) claim 
the OTC market being in rise of becoming an increasingly interesting, attractive, and growing 
area. Though the OTC market at present enjoys a considerably lower growth rate than pre-
scription-only-medicine market, the arising consumer behavior of self-medication by the help 
of the Internet has had a positive impact on the OTC market (ibid). Namely, consumers are 
looking for easing their pains and other symptoms by using OTC products for self-diagnosed 
diseases (Ashman et al., 2007), after searching on the Internet a cause for their symptoms. In 
fact, Blackett and Harrison (2001) claim that over 90 percent of consumers in the US are in 
favor of switching more brands to OTC. 
 
The OTC market also has the ability to help the pharmaceutical companies with patent expires 
and increased generic competition by offering a new, consumer, and brand-based market. 
What is more, since with OTC brands, advertising and other visual marketing is much less 
restricted, the market presents an important opportunity also in terms of branding. Despite, 
there are only relatively few and safe OTC products that have enjoyed companies’ focus on 
their branding. (Blackett & Harrison, 2001; Lyon, 2001; Moss & Schuiling, 2004; Griffiths, 
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2007; Kvesic, 2008). In terms of strengths of OTC brands, there are still quite few strong 
brands especially outside the US.  This has resulted in as Blackett and Harrison (2001) ex-
press it: “There is no pharmaceutical equivalent to coke, ‘the number one cola’ for decades.”  
 
Blackett and Harrison (2001) claim that the OTC market functions much the same as other 
retail markets - that is, in the US. Though the OTC pharmaceutical products are less restricted 
and more broadly sold than prescription-requiring medicines, they are frequently still very 
regulated compared to other consumer goods, especially in Finland. For example, all of Ori-
on’s products are only sold in pharmacies and in pharmacy web stores, which according to 
Lyon (2001), largely affects reachability and vision for consumers. This, so to speak, restricts 
the consumer purchase behavior, as there is only one, rather regulated purchasing environ-
ment the consumer may operate in.  Moreover, pharmacies are specialty stores, where the 
pharmacist may affect the consumer purchase decision to a great extent. 
 
Griffiths (2007) defines that for many companies, focusing on OTC products is an approach 
of building sales and developing new business value, which has resulted in some companies 
to switch from POM to OTC brands. This has been especially common in the US and is pre-
dicted to grow because of the Internet (Blackett & Harrison, 2001). The switching products 
need to be developed for non-serious and easy-to-self-diagnose diseases, contain non-
addictive ingredients, and carry a wide safety margin to prevent overdose. It is also necessary 
that the brand name is transferable from POM to OTC, an ideal being transferring a trade-
mark, which helps to protect the brand from a legal point of view. This will aid the new OTC 
brand to gain existing customers, brand value, and reputation of the old POM product. How-
ever, if a prescription-only-medicine and OTC brand are sold simultaneously, the consumers 
tend to favor the POM brand due to the state funding, which will result in an underdeveloped 
OTC brand and market. (Lyon, 2001) In this case, advertising of the OTC brand will also 
have an indirect effect on the POM brand (Eggleston, 2003). Consequently, switching from 
POM to OTC also benefits governments as the funding costs diminish. 
 
Sanyal and Datta (2011) researched the effect of the country of origin in the category of ge-
neric drugs. In particular, as Orion is the market leader in Finland and is one of the few Finn-
ish pharmaceutical companies, it could be thought that the country of origin has a major value 
in the minds of Orion’s consumers as well. This was actually validated in Kauppinen-
Räisänen et al.’s (2012) study, which investigated the importance of the country of origin in 
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the OTC market of Finland, and found it to be one of the most important attributes. Sanyal 
and Datta (2011) also discovered that the country of origin has an impact on consumer’s total 
perceptions of the brand, and a great, positive influence on brand equity. What is more, Usu-
nier and Lee (2000) explored that the less the consumer is familiar with the brand, the more 
the country of origin influences their perception of the brand, possibly leading to a buying 
decision. Sanyal and Datta (2011), further on, discovered that limited time and product 
knowledge, typically qualities of a “novice” consumer, were also identified as increasing the 
power of the country of origin. They also verified higher involvement products to be more 
susceptible to the concept of the country of origin. As an advice, the authors encouraged 
brand managers to highlight the country of origin in order to enhance brand recognition.  
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3 CORPORATE BRAND DOMINANCE AND CONSUMER  
RESPONSE 
 
Following the literature review on branding, this chapter introduces corporate brands and var-
ying strategies on how to apply them to the product level. The discussion will still maintain a 
broader course and focus on the corporation. Dual-branding strategies will be explained to 
provide understanding for the synergy between the corporate brand and the extension, the 
product brand. Consumers will be the focus in the final section, where it is discussed how the 
individuals experience the influence of the corporate brand. 
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Due to the consumers becoming even more and more educated and capable, it is not only 
product brands that draw their interest. Moreover, consumers are seeking for information 
about the company that manufactures the product, in which case the corporate aspects such as 
corporate responsibility, employee working conditions, and community involvement gain 
attention (Shamma & Hassan, 2011). As written in the previous chapter, consumers are no 
longer solely looking for functional benefits of the products, but stress the importance of the 
emotional values behind them, which is where corporate branding steps in (de Chernatony, 
2002). Namely, Ind (1998) explains that the corporate brand is not only the image or visual 
aspects of the corporation, but the core values that define the corporation. This results in that 
corporate branding includes more than dimensions simply related to products, such as stake-
holder relations and corporate responsibility matters.   
 
According to Roberts and Dowling (2002), corporate reputation affects not only the value of 
the company, but can act as a differentiator when compared to other companies. A positive 
link to financial performance is also found with good corporate reputation (ibid), and Gold-
smith at al. (2000) even state that corporate credibility, defined as the company’s reputation 
for honesty and expertise, is regarded to affect consumer-brand attitudes along with consumer 
responses towards advertising. Moreover, Hall (1993) claims that the corporate brand pro-
vides unique value to the company because it is difficult to imitate and if attempted, it would 
require an extensive time.  
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Following, Shamma and Hassan (2011) draw a conclusion that a strong corporate brand holds 
an important strategic place in the company. It enables the company to attract new employees 
and partners through unique associations attached to the corporate brand, called corporate 
brand equity. According to Shamma and Hassan, the recent studies of corporate branding 
have clarified that companies should no longer only concentrate in harvesting a narrow cus-
tomer group as the only strategic relationship, but to understand the role of other stakeholders 
as well. This is due to positive corporate associations leading to positive word-of-mouth 
communications, which consequently could bring more customers and improve the corporate 
image. Corporate brands, therefore, are no longer seen as apart from consumers. 
 
When compared to product brands, it is evident that the corporate brand usually has a much 
more varying target group and therefore requires varying management (de Chernatony, 2001). 
Berens et al. (2005) add that product brands in general do not evoke same kinds of associa-
tions as corporate brands do; for example, corporate social responsibility and corporate ability 
associations. To consumers these values are, however, difficult to communicate. For example, 
an advertisement in the newspaper about a company building a school in a developed country 
could result in negative consumer responses and even hatred towards the brand, though the 
intention was to communicate corporate brand values. Berens et al. (2005) further explain that 
corporate associations are evoked by multiple sources, which results more confidently held 
impression compared to what is drawn from individual products.  
 
When considering pharmaceutical brands, Moss and Schuiling (2004) state that building and 
maintaining a strong corporate brand can result in clear competitive advantage as it also helps 
to link the products to the brand and differentiate both the company and its products. Howev-
er, according to Moss and Schuiling, pharmaceutical corporate brands are still very weak 
when compared to other consumer brands, and exceeding in this area could differentiate the 
company from others. In addition, building a strong corporate brand may help developing 
more powerful brand portfolios as well as transfer the corporate brand associations to the 
product level, called leveraging the corporate brand (Uggla, 2006). Moss and Schuiling 
(2004), nevertheless, explain that this has not been the reality in the pharmaceutical compa-
nies, where it has been a struggle to even connect brand names to the company name, an effi-
cient tool of corporate brand leveraging. 
  
 17 
8"!"! C;&:;&%+).5&%/0.0;',/%/().
 
 
The amount to which the corporate brand is visibly utilized in product marketing is called 
corporate brand dominance (Berens et al., 2005). Laforet (2011) explains that a considerable 
amount of the branding literature has found the corporate brand positively affecting a product 
brand. While some studies (e.g. Aaker, 1991) proved that corporate brands affect consumers 
in an approach varying from single product brands, Souiden et al. (2006) discovered that cor-
porate brands directly and positively affect consumer’s views on products as well as opinions 
on corporate image and reputation. Furthermore, Saunders and Fu (1997) established the val-
ue-adding side of corporate brands to products.  
 
Laforet (2011) identifies cost effectiveness, improved product positioning, and segmentation 
as benefits of utilizing corporate or single brand in marketing. However, she also defines that 
a recent trend has been returning to using multiple product brands instead of a single brand 
due to not being able to utilize the synergies between corporate and product brands.  Master-
ing these types of extensions is not an effortless task. Corporate branding can at worst cause 
negative associations or lead to dilution of the brand (Leong, 1997), which is why it should be 
carefully thought of in which products it is used. This has been the situation with Nestlé, after 
utilizing the corporate name in nearly all products’ marketing has led to the corporate brand 
becoming somewhat blurry (Saunders & Fu, 1997).  
 
The consumer involvement as well as the product type play an important role in terms of how 
the corporate brand strategy ought to be exercised. Silayoi and Speece (2004) explain that 
with low-involvement categories, utilizing the corporate branding in visual product marketing 
does matter as much as the packaging and colors do. In addition, they recognized that not all 
corporate brands have the same impact on product brands. Namely, the more the corporate 
brand advertises the more value it adds to the product. Laforet (2011) concludes that if the 
company is less known, its corporate brand adds less value to the consumer and therefore 
would unlikely affect their purchase decision. Here, according to Nelson (2002), it would thus 
be wiser to utilize the product brand in marketing. Yet, as Fournier (1998) claims, products 
should not be labeled as only attracting consumers of specific involvement type, but each 
consumer regarded individually. 
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According to Uggla (2006), product brands may be mere extensions of the corporate identity 
and its values, for example, McDonald’s, or the company to revolve around various single 
product brands. Laforet and Saunders (1994) explain this by introducing three simplified 
strategies to structure corporate brand identities and exercise brand synergies of corporate and 
product brands. Firstly, there is Monolithic strategy, where the company uses only one name 
and visual style in marketing, which produces the corporate identity the same as the individu-
al brand to the consumer. This would be the case with a luxury consumer goods brand, for 
example, Louis Vuitton. On the other hand, the company may exercise an Endorsed strategy, 
where the corporate identity is maintained behind multiple products that have their own visual 
look and name. Endorsed strategy generally indicates using a “dual brand name”, which in-
cludes the product’s name as well as the company. An example of this could be Vaasan Ru-
ispalat or Fazerin Sininen, where the corporate brand is mentioned with the product. This 
seems to be a common method among well-known, FMCG brands, especially in the food in-
dustry. 
 
Products may also have their completely own brand identities and names, which contain hard-
ly any link to the corporation. This approach, called Branded Identities, is best seen in Procter 
& Gamble’s and Unilever’s strategies, where the products have their own, strong brands 
(Laforet & Saunders, 1994). Only for a while have these companies mentioned the corporate 
brand in product marketing as well, which could indicate that there is a willingness to transfer 
from branded identities to an endorsed strategy. Moreover, GlaxoSmithKline has shown a 
move from an endorsed to a mono brand strategy, implying that the benefits of utilizing a 
monolithic strategy is also comprehended by a pharmaceutical company. With monolithic 
strategy, corporate brand dominance (CBD) is naturally high, whereas with endorsed or 
branded identities strategies it is diminished. 
 
Berens et al. (2005) also investigated the fit between associations caused by the brand and the 
associations caused by the product, and their moderating effect on corporate brand domi-
nance. According to them, consumers utilize brand images as predictors of product quality. 
Namely, when the brand image matches the product, consumers tend to think that their prior 
knowledge on the brand predicts the product quality as well. Berens et al. even discovered 
that the corporate brand strategy influences consumer product attitudes and corporate associa-
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tions. According to their study, an endorsed strategy should be maintained when products are 
high-involvement type. Consequently, a monolithic strategy ought to be exercised when cer-
tain corporate associations are to be leveraged to the product, especially when the fit between 
the product and corporate brand is proper and the product is perceived as low-involvement 
type. This type of division, on the other hand, struggles to agree with Fournier’s (1998) idea 
of involvement not being the way to categorize consumer-brand relationships. 
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Schuiling and Moss (2004) discuss two methods of restructuring brands and supporting cor-
porate branding: co-branding and brand extensions, the latter which also includes line exten-
sions. By utilizing these dual-branding strategies, the company could leverage its corporate 
brand to the product level as well (Uggla, 2006). 
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Moss and Schuiling (2004) define co-branding as visible alliances of two known brand 
names, developed to transfer their associations, awareness, technical capabilities, brand im-
age, and target market to a new product. The new brand may be created to satisfy completely 
new consumer needs, but it will also aid the old brands to gain new customers, distribution 
partners, and enhance the brand image in addition to even sharing costs of marketing and 
product development. At very simplest, co-branding may only happen in shared R&D, which 
has been the tradition in the pharmaceutical industry. In addition, it could take the form of co-
promotion, again a popular method of pharmaceutical companies. This signifies that two sep-
arate companies act together to promote the same brand name with the same alloy and for the 
same target market. It generally occurs when a company owns a specific compound, but al-
lows another company to sell and market it, sharing the profits. However, due to the weak 
corporate brands and resulting positioning, the pharmaceutical industry has had limited luck 
with successful co-branding. (Schuiling & Moss, 2004) 
 
Jevons et al. (2005) outline co-branding as management’s technique of developing customer 
associations between brands, which Grossman (1997) points out to be especially effective in 
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attaching new brands to existing ones in order to gain the positive associations and images of 
the old brands. Though this, usually, is thought of as a positive process and a benefitting one, 
it may also lead to negative outcomes; for example, if the brands contain varying involvement 
natures (Buchanan et al., 1999). Jevons et al. (2005) provide an example of a retailer utilizing 
high-equity brand to lure customers and at the same time create profit for low-involvement 
brands. This could lead to unwanted brand associations for the high-involvement brand in the 
eyes of the brand owner, since the brand is thus associated with the images of the low-
involvement products. What is more, Perepelkin and Di Zhang (2011) state that consumers of 
pharmacies are generally highly involved and contain knowledge of the products. Neverthe-
less, according to Jevons et al. (2005), brand associations may also lead to customer confu-
sion and consequently lower the brand value. Therefore, brand communications need to be in 
line with wanted brand associations. 
 
On the other hand, Washburn et al. (2000) argue for co-branding leading to increased brand 
equity after forming a unique and differing product, despite there were varying involvement 
categories. Based on this, Jevons et al. (2005) conclude that co-branding should work if the 
resulting associations exceed ones that would have been created by unassociated brands. Rao 
et al. (1999) add that especially valuable benefit would be gained in an alliance where a 
brand’s quality is unobservable. This could easily be applied to Orion’s self-care products, 
since, for example, a gastrointestinal drug’s quality is unobservable to the consumer until the 
product is purchased, swallowed, and its effect experienced. Utilizing Orion’s brand in newer 
products could, therefore, help creating positive brand associations and boost sales. Also, if 
this theory was applied to corporate and product brands, it could either strengthen the brands 
or lead to inappropriate associations.  
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As explained in the first theory chapter, the brand owner, a manager of the company, continu-
ously seeks for procedures to strengthen the relationship and narrow down the gap between 
customers and brands. An approach to this and a method of modifying the brand meanings in 
the eyes of consumers is to develop brand extensions. Brand extensions are methods of trans-
ferring associations of strong, existing brands to new brands. This can be operationalized by 
simply using the existing brand’s name or by developing a whole new marketing strategy. 
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When utilizing the brand name, the new product is associated with the old one and therefore 
acts as a cue for the consumer in representing, for example, the quality of the parent brand. 
Preferably, these associations should be positive and facilitate marketing of the new product. 
(Schuiling & Moss, 2004; Jevons et al., 2005) 
 
Laforet (2011) writes that while brand extensions have been researched to a vast extent, the 
studies have usually focused on consumer associations and perceptions by concentrating on a 
parent brand, typically the corporate brand, and the extension. According to her, a brand name 
is a valuable asset for the company and has a large impact on the consumer buying decision. 
A brand name has the power of associating a product or a service to the company, and these 
associations may contain physical, symbolic, or emotional meanings to the customer. Conse-
quently, utilizing a brand name in packaging or communications may result in various associ-
ations towards the brand though the product was unrelated or unused. Uggla (2006) defined 
this as leveraging the corporate brand. 
 
In terms of extending to unrelated product categories, consumers tend to prefer narrow 
brands. Broader brands, on the contrary, work better than narrow brands when extended into 
an unrelated category. (Laforet, 2011) Hem (2003) suggests that the brand extension should 
fall into the original brand’s category to gain benefits. According to Laforet (2011), success-
fulness of an unrelated brand extension depends on the customer’s response towards the ex-
tension and effect on buying decision. Utilizing a corporate brand extension indicates using 
the corporate brand for a new product or a service (Keller & Aaker, 1998). The best example 
of this type of extension would be S-ryhmä’s own brand, Rainbow, which is sold in all of the 
chain’s stores. 
 
In the pharmaceutical industry, the brand extension strategy can be executed by marketing the 
same product to a variety of diseases with the same brand name or a new one. This can also 
occur in a more extensive approach, where the brand is researched, developed, and launched 
to a number of diseases at the same time, in the same market area. In terms of line extensions, 
pharmaceutical companies may develop new dosage forms; for example, different oral solu-
tions or intravenous forms to support sundry end users’ needs. In addition, the brand may be 
extended by amending the tablet form, for example, to reduced size, content of the active in-
gredient, or to a completely different form such as melt tablets. However, utilizing line exten-
sions is still not well enough understood in the pharmaceutical industry. (Schuiling & Moss, 
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2004) Another way of executing an extension of a medical brand is utilizing the old NME to a 
new purpose or combining it with another NME, which can facilitate reaching new markets 
and maximize the usage and lifecycle of already invented NMEs. This, moreover, benefits the 
consumer as well, since drug efficacy is improved, safety profile enhanced, and novel usage 
patterns found. (Dubey & Dubey, 2009)  
 
Brand extensions do not come without a risk; customer confusion may be created by inappro-
priate brand messages, even leading to reduced brand value. Various studies have investigated 
this problem, and while Keller and Aaker (1992) explored that consumer attitudes of the par-
ent brand do not change after brand extensions, Sheinin (2000) claimed that they do. Moreo-
ver, Martinez and de Chernatony (2004) discovered that the original brand image is diluted by 
the extension. For pharmaceutical companies, brand extensions carry a risk of confusion to 
the consumers, which may result in misuse of medicines. In Finland, there has been discus-
sion on the drug packages resembling each other, which has confused some consumers and 
had the potential to lead to consumption of wrong medicine. Schuiling and Moss (2004) de-
fine the possible confusion as one of the reasons there are so few brand extensions in the 
pharmaceutical sector. In addition, they find pharmacists as one the key influencers restricting 
brand extensions. Namely, pharmacists tend to fear that name extensions would result in dis-
tribution mistakes, which, for example, to allergic consumers could be fatal. This along with 
other reasons has led to the industry not being able to successfully execute brand extensions, 
and there have been only few success stories in the self-care sector. (ibid) According to 
Dubey and Dubey (2009), however, brand extensions carry the opportunity to benefit both the 
company and the patient by creating new markets and extending product lifecycles, and also 
answering to new consumer needs. 
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Laforet (2011) explains that in packages, a corporate name can add value if the consumers are 
familiar with it and it creates something unique. Though she specifically investigated brand 
names, her findings were also extended to visual marketing and in this part match with Berens 
et al.'s (2005) study. According to Laforet, if the product is a public necessity or a luxury 
good, such as a high fashion brand purse, the corporate, core brand values benefit the product 
they are extended into, leading to positive consumer associations and even to a purchase deci-
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sion. This will also happen when a brand name is extended into a category that is similar to 
the established brand, which is in line with Berens et al.’s (2005) research. Namely, the prod-
uct should be fit with the core brand in terms of, for example, visual image, value, personali-
ty, and image in addition to core brand values. According to Laforet (ibid), when the brands 
are in line, a positive brand symbiosis emerges.  
 
On the other hand, if the corporate brand and product brand share no fit or common attributes, 
utilizing the corporate brand’s name or visual marketing will not benefit the extension and 
purchase decision will not be gained. An interesting finding from Laforet (2011), however, is 
that when the core brand is not established, it can still benefit the extended product if there is 
a fit between them, and advertising may be utilized to evoke source credibility and to enhance 
positive usage experiences. Further, communicating the core brand values and emphasizing 
the key brand identity enhances positive consumer associations, possibly leading to a pur-
chase decision. With an extended, low-involvement product a purchase is unlikely to result if 
there is high switching in the market. 
 
Negative consumer associations may also result from utilizing corporate brands in extensions. 
As explained above, the fit between the corporate and extended brand is a key attribute, and if 
there is no such, negative symbiotic branding will result that, further on, can cause negative 
brand associations for both the product brand and the corporate brand. Corporate image could 
also suffer and become diluted in the minds of consumers. (Laforet, 2011) In this case, 
Laforet and Saunders (1994) recommend focusing on product brands rather than trying to 
force usage of corporate brand.  
 
Brand involvement guides choosing an appropriate branding strategy, since associations of 
the parent brand descend to product brands. Laforet (2011) suggests that it is more difficult to 
differentiate corporate branded products than those with their own brand, and that consumers 
can identify products that do not carry the corporate name in them. According to her, corpo-
rate branding may work if the consumers are genuinely interested in the company and associ-
ate the company with a strong identity. In this part her study was in contradict with Berens et 
al.’s (2005) study by claiming that the corporate name does not add value to the product or 
affect the purchase decision. Therefore, regarding this thesis a question arises: How does the 
corporate brand name affect consumer trust, when used in product marketing? This will be 
examined in the discussion chapter. 
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From the academic literature, a simplistic conclusion could be drawn that the closer the brand 
is to the company’s core business, the more value utilizing the corporate brand in product 
marketing will produce. If this was applied to Orion, it would be suggested that with Favora 
and Sebamed, cosmetics brands of Orion, corporate brand or name would not be utilized in 
their marketing, since these brands are the furthest away from Orion’s main business of man-
ufacturing pharmaceutical products. Also, this could be the case with nutritional supplements, 
because consumers might not want to think that they are consuming “medicine” regarding 
these products. On the other hand, since all of Orion’s products are only sold in pharmacies, 
including cosmetics products and supplements, the consumers might choose these products 
over others because of the point of sale environment. 
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4 CONSUMER-BRAND RELATIONSHIPS:  
BUILDING BRAND ATTACHMENT 
 
To investigate what kind of effect corporate and product brands have on consumers of OTC 
products, it is necessary to explore consumer behavior and building emotional attachment 
through branding. As de Chernatony (2002) states, it is corporate branding that best represents 
emotional values of the company. In this chapter, I will present the concept of emotional 
branding, including consumer’s ideal and real selves as well as brand authenticity, and ana-
lyze what constructs consumer loyalty, a main building block being consumer trust. In addi-
tion, I will discuss the consumer-brand relationships and what types of emotions construct 
them. Finally, I will introduce the consumer trust-based commitment process. 
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Emotional branding is defined as the attachment of emotions and a bond to a brand, and is 
found to be one the key branding topics of today (Malär et al., 2011). Consumers are no long-
er seen as passive victims of marketing that only seek for functional benefits of the products, 
but active relationship-forming and experience-searching partners (e.g. Fournier, 1998; 
Valette-Florence & Valette-Florence, 2011). Rossiter and Bellman (2012) introduce five 
widely utilized and known emotions to be attached to brands: bonding, resonance, compan-
ionship, love, and trust – the latter which Blackett and Harrison (2001) as well as Schuiling 
and Moss (2004) defined a value especially important in the pharmaceutical market.  These 
are also emotions Fournier (1998) finds are related to the strongest brand consumer relation-
ships. Thomson et al. (2005) add that brands may use emotions of passion, connection, and 
affection. To consumers, all of these emotions are strong, particular, and usage-specific-type, 
and when properly attached to a brand they bring profitable, loyal customers who do not re-
quire promotion of the brand or a price competition, the traditional challenge in the pharma-
ceutical industry. Thomson et al. even claim that emotional branding may be used as a strate-
gy of differentiating a brand from others, because in reality consumers become attached to 
only a few brands.  
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Creating strong emotional brand attachment towards consumers can increase consumer loyal-
ty, brand defense, and therefore lead to increased profits (Park et al., 2010). Malär et al. 
(2011) discuss appealing to various types of self-concepts of the consumer and its effect on 
consumer emotional attachment. According to them, when communicating emotional brand 
values, the companies should try appealing to the consumer’s self-concept, which has two 
forms: the ideal self and the actual self. The real self is literally the mirror image of what the 
consumer is truly like, whereas the ideal self represents what the consumer would like to be 
and is thus shaped by dreams, imaginations, and aspirations. Consequently, the fit between 
the consumer’s self and the brand’s image is defined as self-congruence and it has the power 
of affecting consumer responses towards a brand. Namely, the closer the brand personality is 
to the consumer’s self-concept, the closer the emotional bond between the consumer and the 
brand is. Despite the importance of addressing the consumer’s self-concept through branding, 
it has been much underestimated before. (Malär et al., 2011) 
 
Through the actual self-congruence the consumer experiences fit between the brand personali-
ty and the actual self (Aaker, 1999), meaning “the brand personality matches the real me”, 
whereas the ideal self-congruence evokes in the consumer thoughts of “I would like to be-
come the image of this brand personality” (Malär et al., 2011). When the brand is congruent 
with the actual self, the consumer experiences positive reinforcement to the self as a result of 
self-verification. This, on the other hand, leads to positive feelings towards the brand, and 
further, emotional attachment. Self-verification is suggested to occur more with higher in-
volvement requiring products, and thus the actual self-congruence is preferred more by these 
types of consumers, Malär et al. analyze. 
 
Malär et al. (2011) present an example of the Dove advertising campaign, which successfully 
appealed to the female consumers by portraying normal weighing women. According to the 
authors, this could be a sign of the consumers looking for authenticity and reality rather than 
something they just wish to be. Controversially, this has been commonly neglected by the 
marketers, as they have focused on the ideal self too much, for example, the mascara adver-
tisements of L’Oréal that include false lashes as well as top models, both far from the reality 
of an average consumer. This can result in negative consumer feelings, if the consumer expe-
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riences the brand being too distant to him or her self-concept. However, these types of brands 
also attract certain consumers because of the aspiration of being something that they are not.  
 
Moreover, when an emotional attachment of consumers is preferred it is essential that the 
consumer self-concept be involved in the process along with self-congruence. Malär et al. 
(2011) explain that both the ideal and actual self-congruencies affect consumer emotional 
brand attachment. However, the actual self-congruence led to higher emotional brand attach-
ment. In addition, the authors state that consumers consume certain products not because of 
simple needs, but because through consuming brands of specific personalities consumers ex-
press themselves and this way seek comfort in using brands that fit their self-concept.  
 
An authentic brand relationship resembles much the above-discussed actual self, as it refers to 
the consumer operating the way that mirrors the consumer’s true self, the actual self. When 
the consumer develops an authentic relationship with a brand, the consumer exposes his or 
her true self, which creates genuine, strong feelings and a bond to the brand, in addition to 
high level of intimacy and trust (Harter, 2002). This, consequently, develops consumer loyal-
ty and the consumer becomes emotionally attached to the brand. According to Malär et al. 
(2011), brand authenticity is especially important in building emotional brand attachment. 
The brand, namely, should not act too unreachable and distant to consumers or otherwise a 
bond with feelings is difficult to form. Brand authenticity seems especially important when 
consumers hold high involvement towards the brand.  
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Fournier (1998) discusses the diverging relationship types in her widely utilized paper among 
relationship marketing literature. Though she notes consumer loyalty to be important, it is 
only one form of a brand relationship in which the marketer should not limit themselves due 
to the existence of also other, valuable relationship types. Brand relationships by nature may 
be functional and utilitarian, or psychological and emotional. At best, the relationships help 
the consumer to fulfill his or herself, whether it is the actual or the real self, leading to intense 
relationships with brands. Through brand relationships, consumers may thus mirror their iden-
tities and new personal attributes such as independence after a divorce or harvest a memory 
after a loss. 
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Fournier (1998) describes six brand qualities to characterize a strong relationship. The first 
one, Love and Passion, is the deepest and most lasting one of all and difficult for the consum-
ers to express, which Papista and Dimitriadis (2012) also discovered. Some studies (Bengts-
son, 2003) even claim that consumer do not experience love towards brands, but it is more of 
a feeling of fondness that they do. Self-connection, on the other hand, refers to what was men-
tioned before: the brand expressing the consumer’s identity. Self-connection may also address 
the past and the anticipated self, much like with the real and aspired self. Traces between the 
personal image of a consumer and the brand’s image were also validated in Papista and Dimi-
triadis’s (2012) study. It could be suggested that through self-connection, the consumers ex-
press their life values in the relationships with brands. 
 
Interdependence, the third quality, is present in routine-oriented brand usage and reflects con-
sumption rituals. An example of interdependence would be a consumer’s tendency to con-
sume the vitamin product during the breakfast in the morning. Following, Commitment is a 
result of holding on to a brand and thus an antecedent of consumer loyalty, Fournier summa-
rizes. The second final brand relationship attribute refers to the brand exceeding its competi-
tors and indicating superior performance in the minds of consumers. In this way, the consum-
ers develop an Intimate relationship with the brand that is highly based on ongoing satisfac-
tion, creating the brand irreplaceable. The final relationship quality is about the brand being a 
relationship partner to the consumer. How does the brand fulfill its partnership role to the 
consumer, is the question. Here such issues as brand dependability and trust become im-
portant and whether the consumer regards the brand placing the consumer’s needs and wants 
first. Fournier defines this type of Brand Relationship Quality much resemble consumer loy-
alty. 
 
Fournier (1998) states that the consumer-brand relationship should not only be thought from 
the functional relationship attributes point of view or based on consumer personal traits. Ra-
ther, the relationships are constructed on goal compatibility and the mutual history the con-
sumer and the brand share. Malär et al. (2011), consequently, identified as one of the key 
trends individual branding due to the increased desire for the brands to resemble the consum-
er’s real self. Fournier (1998) explains this by defining that relationships with brands are 
unique and vary according to the consumer, and therefore can only be understood through 
first studying the life-world of the consumer.  Brands for consumers are partners of their daily 
lives and as such may contain unique memories that in time have evolved to strong and emo-
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tional relationships. Despite, Papista and Dimitriadis (2012) explain that strong relationships 
may exist even if the brand was not used daily or even frequently, and the consumers still be 
committed to the brand. 
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To proceed to the actual definition of the relationship between consumers and brands, Four-
nier (1998) introduces fifteen particular relationships that contain varying labels related to 
friendships, marriages, and affairs. After all, brand relationships do not much differ from rela-
tionships between humans, finds Fournier, though Bengtsson (2003) claimed that a relation-
ship with a brand could not contain feelings of love. These relationship types vary according 
to their need of maintenance, effect on personality development, and also the actual relation-
ship’s development cycle.  
 
There are three relationship types that though are intended for long-term purposes, are not that 
intimate to the consumer. Firstly, Arranged Marriages are frequently derived from a third 
person’s influence and thus non-voluntary. These brand relationships aim at long-term, 
though to a consumer they do not contain much emotional attachment. Casual Buddies, on the 
other hand, is a relationship type that is provoked by situation, has low levels of intimacy, and 
is not intended for reciprocation. Marriage of Convenience, finally, contains commitment 
though it is affected by environmental influences and is more based on accepting a brand to 
replace another. 
 
The most personal and ego-addressing relationships for consumers are ones that are enduring, 
contain high levels of trust and even fondness, in addition to providing constant positive re-
wards. The first one, Committed Partnership, is characterized by voluntariness and includes 
strong feelings of love, trust, and intimacy. Best Friendships are relationships where the con-
sumers expose their true selves to the brands and share common personal interests with 
brands. Then there are Compartmentalized Friendships that are more situational than the pre-
vious two, and include lower levels of intimacy. Despite, they have higher level of interde-
pendence and the consumer develops as well as disposes these relationships easily.  
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Avoidance-driven Relationship / Rebounds well portray negative-driven relationships as they 
are only developed to abandon another brand. Enmities are also negative by nature, as may be 
parts of Dependent relationships. Namely, dependencies are based on obsession and not being 
in the relationship creates uncomfortable feelings for the consumer. This would be a common 
relationship with addiction to something, and in the OTC world this could represent almost 
anything from an addictive use of a painkiller brand to a specific lotion. Secret Affairs resem-
ble this to certain extent as these would be relationships that the consumer would keep away 
from exposure to others and contain high levels of risk as well as privacy. An OTC product 
intended to relieve an embarrassing symptom would be an example. Finally, there are En-
slavements that are also negative and caused by the environment. These are non-voluntary and 
occur because the consumer has no other choice. 
 
The final four relationship types do not follow the same logic as the previous ones in belong-
ing to a certain form. Flings, literally, are short-term relationships that come and go, though 
they provide the consumer high levels of emotional reward. It could be imagined that a very 
impulsive consumer maintains many flings with brands and thus continuously seeks for new 
experiments though there existed satisfaction with brands. This behavior, namely, results 
from the drive to experience. Kinships are non-voluntary and inherited from a relative or a 
family member. Fournier describes an example to be the consumer’s inheritance of a tea 
brand from her mother. Courtships are relationships aiming for commitment, of which an 
example would be a product in trial use. Lastly, there are Childhood Friendships, which re-
mind the consumer of their past self and provide security though usage was infrequent.  
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Following from the consumer-brand relationship typology, the most preferred consumer-
brand type in general thinking is thought to be consumer loyalty, which Fournier (1998) de-
fined as Brand Relationship Quality. Consumer loyalty is in turn affected by trust and com-
mitment towards a brand, as discussed before, which Delgado-Ballester and Munuera-Aleman 
(2001) also evaluate in their study. As Shocker et al. (1994) find, consumer loyalty is espe-
cially important in markets where there is high competition and reduced product differentia-
tion along with rising unpredictability, all characteristics of the pharmaceutical market (e.g. 
Moss & Schuiling, 2004). This is because building consumer loyalty has many benefits, such 
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as increasing profits through less price sensitive consumer base and building an entry barrier 
to competitors. Fournier (1998), on the contrary, defines loyalty to be more than its operation-
al form of consequent purchases or increased amount of spending. 
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According to Delgado-Ballester and Munuera-Aleman (2001), brand loyalty is formed by a 
relationship between the customer and the brand that includes customer trust and commit-
ment. The authors further define trust as “a feeling of security held by the consumer that the 
brand will meet his/her consumption expectations”, and it is formed from past experiences 
and interactions (Rempel et al., 1985). The past experiences may be indirect, thus based on 
advertising, brand reputation or word-of-mouth; or direct, resulting from actual consumption 
or trial. However, for trust to occur, the consumer must have overall satisfaction with a brand, 
which is based on the consumer thinking that the brand holds important the consumer’s wel-
fare and interests (Hess & Story, 2005; Papista & Dimitriadis, 2012) – in Fournier’s (1998) 
paper, called Intimacy. If this occurs, the consumer can rely on the brand satisfying in the 
future as well, despite this had not been the reality before. If consumer trust develops, it leads 
to a commitment towards the brand, which on the other hand increases the price tolerance for 
the product. Simply written, if the consumer trusts a brand, he or she will choose it over oth-
ers because of the emotional attachment – and also pay extra. Trust is thus defined as one of 
the corner stones of building a consumer-brand relationship. (Hess & Story, 2005) 
 
Delgado-Ballester and Munuera-Aleman (2001) identify the moderating variable of trust and 
commitment as well as trust and satisfaction to be consumer involvement. Moreover, when 
the consumer regards information of the product more relevant and is more interested in the 
purchase, trust issues naturally gain importance. This is especially the situation with high-risk 
containing products and products that carry uncertainty (Selnes, 1998), for example, pharma-
ceutical products, and also when there is not enough information provided. Here, the brand 
trust also plays a central role since consumers want to avert risk-taking and therefore seek for 
trustworthy brands to build relationships with.  
 
In building of consumer trust - that has potential to lead to high and profitable consumer loy-
alty - the company must remember that brand trust is an emotion gained with difficulty, but 
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one lost easily. Therefore, authenticity is a key issue and also transparency – as Malär et al. 
(2011) stressed. Information and honest communication with the consumer on brand and its 
values along with acting non-opportunistically could lead to enhanced trust, or at least main-
taining it (Hess & Story, 2005).  In addition, it cannot be stressed enough that the trust is built 
on genuine, authentic promises and attributes for the relationship to be long-term and trust to 
become commitment. For example, if the brand defines its key values as delivering high qual-
ity, corporate social responsibility, and care, these must be shown in its operations as well or 
the consumers’ trust will be lost when the truth is revealed. 
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Valette-Florence and Valette-Florence (2011) define trust as one of the key components of a 
consumer-brand relationship. Moreover, brand trust is associated with brand equity, brand 
value, and brand loyalty (Reast, 2005). Reast also explains that investing in harvesting con-
sumer-brand relationships and consumer trust allows the company to leverage the brand to 
new categories; in other words, exercise brand extensions. Based on Selnes’s (1998) paper, 
the more risk there is associated in a purchase, the more important trust is with a brand exten-
sion. McWilliam (1993) adds here that the better the consumers trust brands that are extended, 
the more willing they are to try the new extensions. In addition, if there is not much direct 
knowledge on the new product, consumers may rely on their beliefs of strong brands when 
considering brand extensions (Hem et al., 2003). Finally, Reast (2003) discovered that the 
more the brands are trusted, the higher their extensions are rated despite these extensions were 
unrelated.  
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Chart 1: Consumer trust formation based on Delgado-Ballester and Munuera-Aleman’s 
(2001) analysis 
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When considering trust in brand extension acceptance, Reast (2005) finds two dimensions 
especially important: brand credibility and brand performance acceptance. Credibility refers 
to the authenticity of the brand and the brand’s ability to deliver what was promised in its 
communication, including personal interaction, packaging, and advertising. The brand must 
be sincere and honest in the eyes of consumers, maintain a good reputation, and carry a con-
cern for the consumers – which again was verified in various other studies (e.g. Fournier, 
1998; Hess & Story, 2005; Malär et al., 2011).  Performance, on the other hand, is defined by 
how well the brand meets its expectation and satisfies the customers. Simply, how well can 
the brand be relied on? In a way, this reminds of Fournier’s (1998) relationship type of Inter-
dependence that denoted to the brand becoming a natural part of the consumer’s daily life. 
Finally, these brand experiences do not necessarily have to be experienced by the consumers 
themselves. Rather, they might be based on word-of-mouth.    
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Hess and Story (2005) define the components of the chronological chain of consumer trust-
based commitment to be satisfaction, trust, personal and functional connections, and com-
mitment. Traditionally, marketers have highly stressed consumer satisfaction as a predictor of 
purchases and profits. However, according to Hess and Story, satisfaction is only one compo-
nent of the committed and profitable consumer-brand relationship and alone does not result in 
trust or commitment. Rather, the trust-based consumer commitment is a complex process, 
which requires different corner stones as building blocks and has moderators affecting the 
strength of it. On the other hand, Papista and Dimitriadis (2012) claim that satisfaction should 
not be undervalued, as it is still a prerequisite of a consumer-brand relationship. 
 
To develop, trust-based commitment requires certain antecedents defined as brand character-
istics, consumer characteristics, product service/performance, and firm responsiveness.  
Though the product quality and consumer trust towards a brand were high, a consumer-brand 
relationship does not necessarily develop. This is due to consumer, product, and brand charac-
teristics moderating the relationship formation, and with specific product categories, such as 
with high-risk containing products, relationships form easily. On the other hand, some con-
sumers prefer to seek for better alternatives and new choices and therefore do not commit to 
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brands. (Papista & Dimitriadis, 2012) Consequently, these consumers would only develop 
Fling-type of relationships with brands (Fournier, 1998). 
 
The very first relationship condition required for a trust-based commitment to occur is con-
sumer satisfaction - that is regularly built on transactional qualities and utilitarian compo-
nents, such as risk reduction, minimized shopping efforts, and efficient information usage. An 
ongoing satisfaction is formed from consistent, individual, and satisfying transactions that 
result in expectations of performance and credibility. Ongoing satisfaction, on the other hand, 
leads to functional connections towards the brand, which are utilitarian by nature and there-
fore represent the shallow connections consumers have towards the brand. In more specific, 
they represent the tangible benefits the brand offers to the consumer, for example, the product 
performance quality. Consumers with functional connections towards brands are more likely 
to recommend the brands over others, while companies with only disconnected consumers 
need to partake in the price competition and execute heavy sales promotions. (Hess & Story, 
2005) 
 
For consumer trust to occur, however, functional connections and ongoing satisfaction is sel-
dom enough. Instead, the relationship needs to be built on personal connections, which ex-
ceed merely utilitarian based benefits. (Hess & Story, 2005) Affiliation, value matching, and 
association are examples of personal benefits consumers gain from brand relationships (Four-
nier, 1998). A personally connected brand relationship requires more time to develop, but 
offers a more flexible, enduring, and even forgiving nature that allows the consumer to trust a 
brand, which in turn leads to commitment. As a result, these types of consumers have a vary-
ing reaction to higher pricing and brand extensions.  
 
It can be summarized that according to Hess and Story’s (2005) trust-based consumer com-
mitment process model, satisfaction and trust together lead to lasting consumer-brand rela-
tionships; in other words, consumer commitment. This process is influenced by consumer 
commitment dimensions that are functional and personal by nature, and their relative 
strengths resolve the nature of the relationships. Though forming relationships and trust with 
customers requires extensive investments and carries risks, it has the possibility of resulting in 
higher brand profits. Moreover, it allows a more competitive market position as well as effi-
cient segmentation by identifying the most profitable customers and permits to target market-
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ing accordingly. In addition, intense customer relationships are a necessary component of 
building strong brands. 
 
 
 
 
Picture 1: Trust-based commitment process model (Hess & Story, 2005) 
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5 THEORETICAL SYNTHESIS 
 
This thesis followed the order of proceeding from larger theoretical phenomena and entities to 
narrower and more specific details. It commenced by introducing fundamental concepts of 
branding, such as brand equity, brand positioning, brand personality, and brand values. In 
addition, the second chapter discussed the special attributes of the pharmaceutical OTC 
brands, since they are quite varying from typical consumer products. 
 
After discussing brands in specific, the third chapter introduced corporate branding – what it 
is and how it can be used in the product level as well. Corporate branding strategies of mono-
lithic, endorsed and brand identities were addressed and further explained what dual-branding 
strategies, in specific, brand extensions and co-branding are. The aim was to explain why it is 
suggested to use the corporate brand in some products’ marketing more than with others, 
which was explained by the fit and nature of the product and consumer characteristics. This 
was all reviewed from the perspective of the pharmaceutical industry, which is found not to 
have used the corporate brand as an extension to the product brands, or focused on building 
strong brands (Blackett & Harrison, 2001; Moss & Schuiling, 2004; Schuiling & Moss, 
2004).  
 
In the fourth chapter, consumer emotional brand attachment was discussed, including such 
key concepts as consumer self-concept, self-congruence, and brand authenticity. In addition, 
consumer-brand relationship typology and relationship quality attributes of strong brand rela-
tionships were explored. This all boiled down to analyzing what constructs consumer com-
mitment towards a brand - introducing consumer trust, ongoing satisfaction, functional and 
emotional connections, and consumer loyalty. As a concluding framework, consumer trust-
based commitment process model was portrayed, including all the above-mentioned concepts 
as corner stones of building trust and resulting commitment. Consumer trust was identified as 
a vital component with medicines since they contain high risk, which the consumers seek to 
diminish (Blackett & Harrison, 2001; Moss & Schuiling, 2004). 
 
To summarize the two theories and present their dynamics, I have developed the following 
graph. It is based on various articles regarding corporate brands, consumer-brand relation-
ships, emotional branding, and also pharmaceutical brands. The purpose is to explain the for-
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mation of consumer-brand relationships and trust of corporate and product brands, which will 
be examined in the empirical part.  
 
My theoretical framework, as I am about to demonstrate, is rather more based on brand con-
sumer relationships than corporate brands. However, I feel that the corporate brand could be a 
powerful influence behind the relationships so it does hold an important place in the frame-
work. Despite, in the empirical part the stress is more in discovering how consumers experi-
ence the brand relationships and what kind of relationships there are, as I defined my research 
problem to be. I will analyze the corporate brand strategies thus based on my consumer inter-
views and this will be executed more in detail in the trust and discussion sections. 
 
The following framework consists of three acting agents: corporate brand (Orion), product 
brands (e.g. Burana, Multivita, Aqualan L), and the consumer. I will investigate the corporate 
brand product brand relationship from the viewpoint of corporate brand dominance based on 
Laforet and Saunder’s (1994) and Berens et al.’s (2005) studies along with other corporate 
brand research in minor part. Secondly, product brand consumer relationships will be studied 
based on Fournier’s (1998) consumer-brand relationship typology and relationship quality. I 
will also research the consumers’ emotions towards brands based on Hess and Story’s (2005) 
article of trust-based commitment process and Blackett and Harrison’s (2001) definition of 
trust being a central emotional value of medication. Lastly, I will concentrate on a particular, 
strong brand relationship by building a case-type examination according to Fournier’s (1998) 
relationship attributes. This well explains the complexity of the subject of the thesis and sub-
stantiates the lack of a specific theory. 
 
In particular, I am interested in discovering what kind of consumer-brand relationships there 
are, how the consumers experience them, and what kind of emotions are included in the rela-
tionships. Thus, the interconnections between the brands will be studied based on the con-
sumers’ experience. Since this is a qualitative study, the idea is not to derive straightforward, 
simplistic relationships but to uncover how the relationships are formed and develop in time, 
regarding consumers as individuals. Finally, my research methods will be very informal and I 
will keep my role to the minimum in the actual interviews, which is why not all the aspects of 
the theoretical framework are examined in the empirical part regarding each individual. 
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Corporate brand Strong image,  
holds positive and  
meaningful  
associations  
and values in  
consumers’ minds 
Product brands 
Consumer 
Leveraging asso-
ciations from 
corporate level  
• Brand image 
• Customers!
• Reputation!
Consumer  
emotions: 
• Satisfaction 
• Trust  
• Commitment  
• Loyalty 
Consumer  
identity: 
• Real and 
ideal selves!
     Burana                       Multivita                   Aqualan L
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Arranged Marriage Marriage  of Convenience Casual Buddies 
Committed  
Partnerships Best Friends 
Childhood  
Friendships 
Compartmental-
ized Friendships Kinships 
Avoidance-driven 
Relationships Courtships 
Dependencies Flings Secret Affairs Enmities Enslavements 
Table 1: Theoretical framework for the empirical part 
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6 METHODOLOGY 
 
This chapter will begin the empirical part by introducing the case company and the methodol-
ogy used. The best technique for conducting this type of research is defined to be qualitative 
interviewing and more specifically, existential-phenomenological interviews. The interviews 
were conducted during two weeks and there were in total seven interviewees, some of which 
were interviewed twice. The data analysis follows clauses set by existential-phenomenology: 
the stress being in interpreting the experiences lived by the consumer from their aspect instead 
of providing objective, theoretical assumptions or comprehensive sample of specific kind. 
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Orion, a Finnish pharmaceutical and diagnostic test manufacturing company was formed in 
1917 and has since globally marketed, developed, and sold pharmaceutical products to con-
sumers and medical entities. Orion’s product portfolio consists of proprietary products, spe-
cialty products, animal health products, and Fermion Oyj’s products, which are active phar-
maceutical ingredients manufactured for the company’s purposes and to be sold outside. In 
addition, Orion Diagnostics sells diagnostic tests and machinery used for patient treatment 
and follow-up purposed. The only distribution channel Orion’s products are sold in Finland 
are pharmacies. (www.orion.fi) 
 
As outlined in the introduction part, the focus of the thesis will be on Orion’s self-care (OTC) 
pharmaceutical product brands because these alone form a vast part of Orion’s product portfo-
lio and provide more insight into branding due to the marketing being much easier than with 
prescription medicines or other categories (Blackett & Harrison, 2001). Regarding this study, 
self-care products are defined as products that do not require prescription to purchase and are 
directed to humans. The definition, therefore, expands the channels to retailing because it is 
allowed to sell cosmetics products and supplements there and in the future perhaps even 
milder pharmaceutical products. For Orion, self-care products are positioned in the specialty 
products category along with generic products and off-patent products.  
 
Selecting a case company provided certain benefits that focusing on multiple medical compa-
nies might not have done. Firstly, Orion is probably the best-known pharmaceutical company 
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among the Finnish consumers. As identified in the theoretical part, the visibility of medical 
companies to consumers is an ongoing challenge. Asking about experiences related to, for 
instance, Pfizer would not presumably result in as much variation and rich descriptions as 
with Orion because consumers are not familiar with the corporation, but only the single prod-
uct brands. Nevertheless, Orion will only be used when examining the corporate brand, and 
product brands may be manufactured and marketed by various pharmaceutical companies. 
This is because multiple times the consumers were not even aware of the corporation behind 
the product or had interesting relationships with brands of other pharmaceutical companies. 
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The research method of this thesis belongs to qualitative marketing, which offers many ad-
vantages regarding this type of research and compared to quantitative methods. Firstly, as the 
objective of the study is to discover emotions consumers hold towards brands, a survey solely 
would not be enough to explore how consumers actually feel that McCracken (1988) believes, 
may be hidden behind the words or discovered in utterance. McCracken also confirms that 
compared to quantitative research, qualitative methods seek to understand the interrelation-
ships between the analytical categories under studying rather than isolating the categories and 
explaining the relationship between a narrow set of them. This is especially important in this 
research since due of the lack of a clear, unified theory, investigating multiple interrelation-
ships among the brand hierarchy is justified. 
 
In addition, qualitative research offers a more dynamic approach because the investigator has 
the option to influence the research process as it proceeds, by posing various kinds of sponta-
neous sub-questions or simply listening to the respondents’ narratives. The qualitative pro-
cess, therefore, is considerably less strict than quantitative and also less organized, which 
generates the approach complex.  In addition, McCracken (1988) outlines that the respondents 
must use more of their own knowledge and thinking than with quantitative research, which 
commonly has answers prepared to choose of. It could be thought that the qualitative process 
for the respondent is more intensive and for the investigator provides richer understanding of 
the consumer, in particular, in what is left unsaid but expressed in non-verbal communication. 
This was also seen during the interviews when the consumers would stress certain words with 
their tone to truly emphasize them. 
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Disadvantages of qualitative research are the limited time the respondents have and their pri-
vacy-matters (McCracken, 1988), which was also noticed when preparing for the data collec-
tion. In addition, as the consumers are extremely busy and perhaps security concerned when it 
comes to a taped interview and open-to-public thesis, it is difficult to have respondents sit for 
many hours and openly discuss their lives, especially their consumption of remedies. Howev-
er, if trust between the investigator and the respondent is constructed by correct ways, the 
interview process offers a means for understanding how the consumer encounters the world, 
which is the aim of a qualitative study (ibid), and also of this research.  
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Since the research problem is multisided and requires deeper investigations into the consum-
er’s mind, an interview where the investigator has the option to influence the process is best 
suited as a data collecting method. As Papista and Dimitriadis (2012) define, consumers do 
not prefer discussing strong emotions with brands similarly as they would perhaps do with 
humans. Hence, the focus will be more on how they tell the stories and what kind of life-
situations, people, and values are involved to enrich the analysis. Finally, since medicines to 
consumers are a not like foodstuff, but a sensitive subject, there is a need to build a connec-
tion and trust before the interviewees will open up and honestly depict feelings. Due to this, 
interviews were sought to keep personal and relaxed by nature, as well as regarding some 
participants, second interviews were conducted. 
 
McCracken (1988) advices that the investigator should not use active listening skills when 
interviewing, but rather techniques that include gestures encouraging the consumer to contin-
ue discussion and explore what he or she prefers, not the questions the researcher has devel-
oped beforehand. Unstructured and exploratory are the words to describe what qualitative 
interview process is at its most effective like. Despite the suggested nondirective and some-
what unorganized nature, the investigator should nevertheless exercise certain control over the 
interview, but the control should be demonstrated in identifying key terms and asking elabo-
rations, not forcing words to the consumer’s mouth, explains McCracken. The interviewees 
should be encouraged to develop conversation and provided with plenty of room to narrate.  
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The purpose of the empirical part is to investigate the research problem from an in-depth view 
and thus utilizing the method of existential-phenomenological interviewing is argued for. 
Namely, the purpose of this methodology is to provide rich, non-dualistic, and first-person 
understandings of the respondent’s life as they themselves see it, not as the interviewer does 
(Thompson et al., 1989). The emphasis is on the respondents depicting how they have experi-
enced situations and matters, which is a proper method of investigating brand relationships 
since brands merely exist in the consumers’ minds and experiences. The method was also 
exercised by Fournier (1998) in her investigation of consumers’ relationships with brands. 
Thompson et al. (1998) further mention that the purpose behind existential-phenomenological 
interviews is not to provide an objective description of a causal relationship, but rather lived 
experiences of the consumer to explain meanings resulting from them. 
 
The nature of an existential-phenomenological interview process is loosely structured and 
informal (Thompson et al., 1989). This represents that the respondent is more in charge of the 
interview, and the interviewer’s role is to follow through what the respondent describes. 
Thompson et al. even claim that there should be no predetermined questions involved, but 
simply an opening question and a resulting, flowing conversation. To exercise this method, 
Thompson et al. suggest utilizing such descriptive question forms as “Can you tell me 
about…”, “How was it like”, and “How did you feel when…” Why–questions, on the other 
hand, should be avoided since they may provoke the respondent to rationalize their thoughts 
too much as the aim is to discover lavish descriptions of the respondent’s life-world and expe-
riences. The questions should be short and descriptive to encourage the respondent freely de-
scribe experiences. What-questions may be used for asking for an explanation (Thompson, 
1990), especially when using the technique of “playing dumb” (McCracken, 1988) and seek-
ing for the interviewee to explain their terms. 
 
However, though there were no actual questions, certain themes can still be developed be-
forehand (Thompson et al., 2006) and the interview to include “grand tour” questions regard-
ing the interviewee’s life, background, and experiences of brands. These questions can serve 
as building trust and creating feelings of comfort, which is why they should be kept relatively 
informal and short. (McCracken, 1988) Further on, Thompson et al. (2006) even provided 
their respondents a list of predetermined topics that would be investigated in the interview. 
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Their purpose was not to guide the interview, though, but to provide the respondents subjects 
to grasp on if there were silent pauses during the conversation. This way, the purpose of exis-
tential-phenomenological interviewing was kept alive by the interviewee having the control 
and the situation proceeding in their terms. 
 
When interviewing the respondents, Thompson et al. (1989) suggest the interviewer to exer-
cise great caution towards confidentiality and protecting privacy. This is conducted by ex-
plaining that the interview is recorded along with defining the purpose of the research, and 
that an in-depth analysis will follow afterwards. The respondents are also promised anonymi-
ty and before the actual interview, their consent requested. This is all performed to avoid any 
ethical concerns that may arise from this type of method, where the stress is on finding deep 
emotions and personal experiences as well as relationships and underlying feelings. Due to 
the privacy matters, one interviewee felt afterwards that they did not want to participate in the 
study though the instructions had been discussed thoroughly beforehand. Naturally, this inter-
view will not be included in the thesis. Moreover, the data analysis has been provided to all of 
the interviewees to view before publishing, if there was something to be altered. 
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Regarding the interviews, a questionnaire had not been developed beforehand as was suggest-
ed by Thompson et al. (1989; 1990; 2006) when conducting an existential-phenomenological 
interview, but there were certain themes developed in advance. As written, the interview 
would be categorized as an unstructured and informal. This was seen in first conversing with 
the respondents about their lives and other unrelated matters to build conversation and trust in 
addition to easing the nervousness experienced by certain consumers, probably due to taping. 
The interviews had two sides: firstly, a personal profile of their consumption was to be built 
that would include studying the respondent’s life values and history to certain extent, and sec-
ondly, to explore the consumption experiences with OTC medicines. Consequently, in the 
analysis part the consumption experiences of certain brands could be affiliated with the spe-
cific brand relationship forms (Fournier, 1998).  In addition, life experiences related to con-
sumption of self-care medical products were sought and if there were other persons, places, or 
specific situations involved.  
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Moreover, there was an interest in discovering how the corporate brand of Orion addresses 
the daily lives of consumers, and how they transfer these emotions into actions when selecting 
also other or new OTC brands belonging to the Orion brand family. The purpose was, fur-
thermore, to discover what kind of life situations there were related to these brands and how 
the brands were seen in the consumers’ personal relationships. In order to encourage conver-
sation, some of the respondents were requested to bring a self-care pharmaceutical product 
they were most fond of to the interview. This was performed so the interviewee would have 
something concrete to discuss and associate feelings to, in addition to aid the research due to 
not having questions. What is more, the advertisement of Orion included in the appendices 
section (Picture 2) was brought to provide help if needed. However, the advertisement would 
only be introduced if there were silent times, as Thompson et al. suggested (2006), in order to 
maintaining the leading role of the respondent. In addition, due to not having practically any 
experience of this type of very loosely structured interview, it was justified to follow Thomp-
son et al.’s (2006) footsteps of developing a short list of themes to be covered in the interview 
and provide it to the respondent. These themes addressed consumption of OTC products, 
trust, corporate brands, and the quality of being Finnish. 
 
 
 
 
 
 
 
Picture 3: Respondent’s favorite OTC products 
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The interviewees were chosen from my extended network due to the difficulty of attaining 
random interviewees who would have the time discuss their lives, and moreover, such a deli-
cate subject as medication and even illnesses. The purpose was not to distinguish the respond-
ents based on their demographical information so this was not paid attention during the selec-
tion. However, both genders were interviewed to see if this affected anything in addition to 
finding people with different lifestyles. Also, the respondents’ willingness to participate in the 
interview was a key attribute of choosing because then it was known that there was motiva-
tion to talk about the topic, especially if the respondents themselves asked to be interviewed. 
For participating in the interview, Orion provided the respondents a product package to thank, 
and in total six in-depth interviewees were attained, which was an amount enough suggested 
by McCracken (1988). The background data of the respondents is summarized in the Table 2 
found in the appendices section.  
 
Compared to Fournier (1998), the interviews were not as extensive and the sample was larger, 
but still the emphasis was on quality rather than quantity. This was seen in focusing mostly on 
only five interviewees in the consumption analysis part and also conducting second inter-
views with certain persons. However, though Fournier’s means of investigating both the life-
story and brand usage of a consumer were followed, the stress was more on brand usage than 
extensive life story telling that Fournier had. This seems reasonable since Thompson et al. 
(2006) mostly concentrated on the interviewees’ attitudes towards coffee shops rather than 
their life stories, though using the same methodology as this research. In addition, the sample 
of this thesis consisted also of men. Although Fournier based her selection of interviewees on 
the claim that women would experience emotions stronger, Rossiter and Bellman (2012) 
found that emotional branding is as effective to men as it is to women. This is a fascinating 
issue to be investigated in the empirical part. 
  
The interviews begun by asking certain “grand tour” questions (McCracken, 1988) of the 
consumers’ lives and backgrounds, even though they would already be known, along with 
questions of usage experiences of self-care medication and related opinions. In addition, the 
topic of the research was explained and the purpose behind conducting these types of inter-
views. Also, the data analysis method of utilizing their personal experiences and thoughts was 
discussed, added to that the study would be executed in co-operation with Orion. It was also 
reasonable to explain what was indicated by self-care medication and what kind of brands it 
included, to establish their understanding. Many were concerned that they were not currently 
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using any self-care medication, so the purpose being in investigating their whole lives’ expe-
riences was explained. Afterwards, it was made sure the interviewees were comfortable with 
all of the above and when agreed, recording of the interview begun and the opening question 
was asked, which varied according to the situation, but encouraged the consumer to explain 
their usage experiences of OTC medicines.  
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Thompson et al. (1989) write that, chronologically, after the taped interviews have been tran-
scribed, the analysis phase begins. This may occur already during the interviews, which signi-
fies that not all the interviews have to be finished in order to analyze the prior ones. Again, 
the stress is on understanding the experiences lived by the consumers rather than creating 
conceptual, unified hypotheses and causal relationships out of the data. The goal of existen-
tial-phenomenology is to be empirical and any interpretation or conclusion must be supported 
by empirical evidence of consumers’ lived experiences (Thompson et al., 1989). In other 
words, the findings of the research, the themes, must emerge from the respondent describing 
an experience and not from theoretical assumptions. The research, therefore, should be free of 
personal assumption and contain other people to agree with the conclusions of the research, 
which naturally are supported by the empirical evidence. The latter Thompson et al. define 
especially important, because the interpretations should be something seen by also others, not 
based on the researcher’s own dogmas, superstitions, or prejudices, which indeed is one of the 
challenges of this methodology. 
 
Thompson et al. (1989) suggest treating data as “an autonomous body of data”. According to 
them, autonomous refers to methodological matters. Firstly, the respondents’ description of 
their lived experiences is believed without the need to verify the statements by external cues.  
For example, if a respondent were to describe a situation with a strong feeling, there is no 
need to authenticate the statement by investigating if the emotion actually existed, but the 
importance is on discovering the meanings behind the feeling. Secondly, Thompson et al. 
claim that the researcher should not combine the respondent’s stories with hypotheses or theo-
retical terms that are apart from the interview. Thus, there should not be assumptions that the 
respondent implied something they did not express, because the interviewer must believe the 
respondent’s experiences as they are presented.  
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When analyzing the data, Thompson et al. (1989) identify the need for bracketing the theoret-
ical definitions behind the research. The theoretical assumptions and the interviewee’s experi-
ences must be analyzed from a non-dogmatic viewpoint. Hudson and Ozanne (1988) write 
that the researchers sometimes have difficulties bracketing, which Thompson et al. continue 
to perhaps result from the unavailability of proper methods to do it. They thus suggest utiliz-
ing an interpretive group of researchers to provide multiple interpretations in order to allow 
bracketing. 
 
On the other hand, McCracken (1988) claims the best way to analyze qualitative data is to 
think how the researcher him or herself would experience the phenomenon and what thoughts 
it evokes in the researcher. This is in conflict with Thompson et al.’s (1989) definition of the 
research to be regarded only from the viewpoint of the respondent and the interpretation not 
to contain the investigator’s own assumptions, prejudices or objective conclusions. If I were 
to consider my own consumption of medical products and reflect it to the interviewees’ sto-
ries, assumptions could easily occur because then I would compare their experiences to my 
own. Hence, the focus will solely be on the respondents’ experiences and lived situations as is 
suggested by Thompson et al. This is also one of the reasons there are no questions developed 
in advance except for the first one that in fact varied according to the situation. 
 
For the concrete method of analysis, the consumption profiles were constructed already in the 
meantime while conducting other interviews. This way it could be seen what kinds of themes 
were brought up and focused on these regarding new interviews or conducting second inter-
views. The consumption profiles were built by utilizing idiographic analysis methods 
(Thompson, 1989; Fournier, 1998) of focusing on the single case and not deriving compari-
sons at this stage. This was performed due to the willingness to understand each consumer as 
an individual and not permitting assumptions guide the analysis. The second part of the analy-
sis gathers around themes that have occurred in the interviews as a whole, in which coding 
was used to derive these from the text. There the concentration will also be on evaluating why 
consumers either share same themes in their experiences or do not. This will thus unfasten 
from the strict guidelines of existential-phenomenology. As the interviews were conducted in 
Finnish, they have been translated to English rather freely, but as written, the analyses have 
been shown to the interviewees to attain their consent and for them to view if something is to 
be amended. 
  
 48 
7 EMPIRICAL FINDINGS 
 
 
The findings will be divided into two: explaining the consumption of selected respondents 
and then discussing the larger themes that emerged in the interviews. Firstly, I will present the 
consumption behavior of OTC medicines of selected interviewees. This is performed in a 
phenomenological, idiographic method, where I will only focus on describing the consump-
tion through experiences and their attitudes. Secondly, I will discuss what truly forms their 
trust towards the OTC products since here the corporate brand may be examined. Lastly, 
brand relationship types of the consumers will be analyzed and brand relationship quality of 
one consumer and her favorite OTC brand introduced. 
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Before beginning to discuss the themes that came up in the interview, I will provide introduc-
tions to the interviewees’ backgrounds and their consumption. This is to help understanding 
their consumption and how the life values affect it, therefore partly addressing the first re-
search question and completely the second. Moreover, I feel that it provides a deeper under-
standing on how their experiences, thoughts, and attitudes are constructed, in addition to how 
their life values affect consumption of OTC products. I have only left one interviewee out of 
this section due to the similarities with another consumer.  
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Mika is a 24-year old postgraduate of two degrees, currently living in the city center of Hel-
sinki but originally comes from Eastern Finland. Mika moved away from his childhood home 
to live in another city already at the age of 16, in order to study in a good school that offered 
an international secondary school degree. He now lives in a small apartment with his sister 
and actively studies both economics and humanistic sciences. In addition, during the two de-
grees he has maintained two jobs, which results in him being extremely busy and thus also 
affects his consumption of pharmaceutical products. In fact, from all the interviewees, Mika is 
the first and only one to embark on a discussion of the poor availability of medicines, already 
in the beginning of the conversation. As he describes:  
 
  
 49 
M: In Finland, self-care products are very poorly available in pharmacies and supermarkets. I 
would really want them to be sold in other stores. 
I: Oh you would? 
M: Yeah, of course, because when pharmacies are only open for a certain period during the 
day it is hard to get medication from there. It would probably be much easier if they were 
available in grocery stores. 
 
Mika explains that he sometimes shops for moisturizing cream from the pharmacy during 
Saturday night. For most of the people, this would probably be a time to be doing something 
completely else or they would purchase the product from a grocery store while shopping for 
something else. Mika, on the other hand, goes the extra mile to fetch the cream from a spe-
cialty shop. He also tells that his consumption is much driven by what he needs, not what he 
desires. In addition, price-consciousness is a key value close to Mika. This he discusses when 
distinguishing his and his parents’ consumptions: 
 
M: They consume much more than me, because I try to consume the minimal amount. It is so 
that I don’t want to consume much since it takes a lot of money and then I want to live sim-
plistically. Like only for the subsistence. 
I: What do you mean by subsistence? 
M: Well the consumption only for staying alive.  
 
 
When compared to an average consumer, Mika has much more information about medical 
products due to having studied biochemistry in the university. This, he says, is one of the mat-
ters that affects his brand selection and purchase behavior. When shopping in the pharmacy, 
he first asks the pharmacist the price and then what are the active ingredients in the product, 
and which of those affect his health. Mika also depicts to google how the medication affects 
one’s body, in terms of how the active ingredients engage with cells. For example, he never 
purchases a product that includes lactose though he is not allergic. In this fashion, Mika is a 
perfect example of the modern, demanding, and educated consumer of OTC products (Black-
ett & Harrison, 2001). 
 
When selecting OTC brands, price is the most important factor for Mika. He identifies not to 
be very brand loyal and always purchases the product that is the least-expensive one and con-
tains the largest quantity. In addition, there seems to be confusion about brand names. 
 
M: I’ll buy that Ibumax. Or the one that is the cheapest, I don’t remember what it is called, 
ibu, what’s the name of that? Well anyway, Ibumax or Ibusal. The one that you get lots of 
with a cheap price. 
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Despite the price and ingredient-consciousness, Mika tells that he may as well change a brand 
if the pharmacist argues well for the product and demonstrates that it is better than what he 
has been using, therefore permitting power to the pharmacists and challenging them. Mika 
outlines an example of Aco moisturizer, which he received from his mother as a Christmas 
present and has been using since. One particular time as he went to purchase it from the local 
pharmacy, the product was sold out and the pharmacist did not even care to present other 
products. This resulted Mika to leave the store, proceed to another pharmacy, and experience 
extreme disappointment.  
 
M: Well it was just that Aco cream, because I wanted just that moisturizer, and they did not 
have that. If they would’ve presented some other options, like if they had Vichy creams or 
other pharmacy products, I could have bought it without a doubt - if they had presented the 
benefits of the product and argued well for it. Like buy this and don’t buy that, because there 
is less oil in this and it’s more moisturizing for your face, but since they didn’t even try, of 
course it affected my choice. But it’s more like a wholesome experience, I can change a brand 
if I get good justifications for that in a service form. It’s like a unified package. 
 
This, service-stressing attitude of his is further seen when he is simply being asked about an 
event when purchasing a product from the pharmacy. Consequently, Mika becomes passion-
ately inflamed and reiterates that the service was so poor and the pharmacist seemed “mean 
and repulsive”, which was extremely upsetting. This is because Mika values the human con-
tact when shopping and also being closer to people “more than an average Finn”, therefore 
distinguishing himself from others, yet again. Having traveled around the world, Mika also 
draws a comparison between the Finnish service culture and what exists in the Western Eu-
rope.  
 
M: Well I think that the difference is shown in Finland there that they just do their jobs and 
when they have a bad day, it shows in their service. That I don’t like, when personal issues 
affect your job. It shouldn’t be like that. 
 
 
Mika continues the story and explains experiencing that he was not served because of his 
clothing and that the pharmacists probably established their kindness on how much the con-
sumer spends.  
 
M: She was like so repulsive and mean, I thought how does this pharmacy even exist if eve-
rybody gives as poor service as she does. I just thought she only served old ladies well, be-
cause there are a lot of them living near. I felt like that, because the other person [pharmacist] 
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was serving an old lady who was getting a whole bunch of prescription medicines and I was 
only getting a facial moisturizer. And then when I went there, I had sweatpants on. Well you 
don’t think every Saturday night when I go shopping for facial moisturizer that I would put 
some kind of suit on. 
 
Mika lists that in his life, such matters as friends, family, studying, and parties as well as free 
time are important factors. However, he especially stresses succeeding, which he then contin-
ues to detail: “Well, getting a good job or studying place. To do what’s fun.” This is also seen 
in his lifestyle of trying to achieve as much as possible already in the young age. That said, 
during the past five years he has almost completed a master’s degree in economics, bachelor’s 
degree in humanistic sciences, studied abroad biochemistry for a year, and served in the mili-
tary, in addition to maintaining the two jobs. When continuing the conversation on his values, 
he begins:  
 
M: Well, maybe I’m a bit of an individualistic person. I do care about other people, but still. 
I: Tell me more about this individualism? 
M: Well maybe in that sense that I don’t really care about what others think of me. Maybe it’s 
something like a good self-esteem, and that’s my value. Not being egoistic, but like being 
who I am and so on.  
 
This Mika portrays is seen in his consumption of also OTC medication - he does not buy 
“brand medicines” or if he purchases inexpensive products, he does not mind if the pharma-
cist thinks of him as poor. Mika further renders his relationship with OTC medicines being a 
“healthy” one, and that he does not employ medication for a minor headache, “only when it is 
necessary”. He explains that due to this, he seldom preserves painkillers stored at home be-
cause he always consumes them for the need. Afterwards, Mika begins to depict the latest 
experience he had when consuming analgesic drugs. It was a journey to London he embarked 
on though he had caught a dreadful flu and suffered from a soaring fever. There, the OTC 
product rescued his vacation. 
 
M: It was a summer there [London] so that already healed me mentally. But I didn’t realize I 
was sick and then I just walked around like 25 kilometers everyday, and I even lost my toe-
nails because of that. Then I just took Ibusal, I used it for the flu, so I wouldn’t feel myself 
sick and could just do as much as possible. Which isn’t really smart but it helped a lot. 
I: Tell me about the feelings you experienced during this? 
M: What kind of? Well positive in that sense that I could be and feel myself healthy though I 
was actually extremely sick. I could go everywhere, like being outside because the weather 
was so good, go shopping, and meet my friends. 
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When talking about vitamins, on the other hand, Mika mentions that it is partially preventive 
consumption, which in his words implies to simply averting diseases. To him medicines are  
“a tool for a better life and wellbeing”, which was also seen in consumption of Ibusal in Lon-
don. Mika admits that when suffering from a cold, he is no stranger to consuming considera-
ble amounts of painkillers. He even admits to use his family members’ prescription medi-
cines, if they help. Therefore, his trust towards medicines is rather immense. 
 
When Mika initiates a conversation on his usage of a vitamin D product, he explains that 
there exists “no trust that content is 100% vitamin”, and specifies that the amount of the vita-
min mentioned in the package is not necessarily included. This is because he realizes that 
there are flaws in the world and corporations can deceive people. However, Mika explains 
that since the vitamin products are sold in pharmacies, they ought to be trustworthy.  In addi-
tion, a central component in creating his trust is to espy that the product works. This might be 
problematic with vitamins, because not catching a disease could be a result from other causes. 
Regarding painkillers it is another story, since when the product takes away the pain, the effi-
ciency is proven with his own eyes. 
 
When Mika explores his relationship with being Finnish, he defines that one of the core val-
ues of the Finnish people is not to act like what they are not, thus maintaining true to them-
selves. Authenticity (Malär et al., 2011) is therefore important to Mika. He also criticizes 
people who are too decorative and ones who purchase products “without purpose”. To Mika, 
the basic cornerstones of life are more important; for example, having a decent place to live, 
in addition to leading a hedonistic life. When depicting his consumption in general, Mika 
mentions not to own a smartphone - not because he cannot afford it, but because technical 
devices do not interest him. Although, Mika later specifies that if his earnings were more 
comprehensive he could as well spend money on technology, but even then he would not pur-
chase “a Swarovski crystal decorated TV”. 
 
M: It is I, myself that decides precisely what interests me and then I purchase those kinds of 
products. 
I: What are those kinds of products? 
M: Well, for example, good food, and then eating at restaurants. Also something like cham-
pagne, alcohol. When I went to Portugal, I brought all kinds of wines and Port wine from 
there. I’m not an alcoholic or anything like that, but I’ll spend money on all kinds of delica-
cies. Technology, I couldn’t give a crap. 
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Though Mika at first does not admit having any strong brand relationship, he eventually en-
ters a discussion on a nasal spray brand. The product is called Nasolin, which he shares a long 
relationship with. Nasolin was introduced to him already in the childhood by his mother, who 
used to apply the spray to him during sickness. When describing the relationship with Na-
solin, he tells that it is a warm one, and portrays it as a symbiosis where he benefits from con-
suming the product. Mika even remembers what the package looks like in detail, though he 
does not know who manufactures it. In addition, his relationship with the product does not 
limit to the sickness seasons, as he tells: 
 
M: It’s like you become addicted to it in someway. I’ve used this product called Nasolin. I 
used the product when I was sick and I continued to use it when I felt even a bit of coryza, I 
had to have it.  
 
At this point, when asked about the price that to him is an important factor, Mika surprisingly 
mentions not take it into account regarding this product. This, however, seemingly arises dis-
tress in Mika and he commences to rationalize. 
 
M: I don’t look at it [price] much. I could ask the pharmacist if there was another product. If I 
noticed it costs like 500 euros, I would probably ask them if there was a cheaper one. In fact, I 
think I will. Perhaps if I now went shopping, I would ask them. 
 
 
 
Mika’s keywords: Preventive consumption, need-driven consumption, service stressing, 
price-consciousness, brand loyalty, savior, individualism, hedonism, authenticity. 
Components of trust: Finland, assessing the products through own knowledge, pharmacy. 
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Sara, a 21-year old female, is a student of polytechnics and lives in Helsinki, but originally 
comes from a smaller sized town. She occasionally works in a clothing retail store but mostly 
focuses on school and student life. Her hobbies contain playing piano and practicing martial 
arts, the latter in which she has actively competed in the national and international levels. Her 
current lifestyle of being a young student reflects her consumption of OTC medication, as she 
tells to first construct her criteria of selection purely on the price. Sara begins to talk about her 
purchasing behavior of analgesic drugs. 
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S: Well I don’t usually buy Burana because it’s more expensive than Ibumax. Or is it even 
Ibumax, or Ibusal? Anyway, Ibumax has become to me, well like I’ve started to think that it’s 
the cheapest one, so I don’t even look at the price now but just grab it from the shelf because 
I’m used to it being cheaper than some kind of Burana. 
 
Therefore, it is not only the rational motive of price that in reality guides her choices, but the 
habit and the mental image of this specific brand carrying the least expensive price. In addi-
tion, due to the sports background, she says to have consumed ice bags that are sold in phar-
macies. Neither regarding these products does she consider the price, due to the habit and 
functional benefit of durability. 
 
S: I just noticed that I have also had them before, like at my parents’ house, so I knew they’re 
good and then I just realized I don’t have them and I need them. Then I just purchased them 
and didn’t even look at the price or go to another pharmacy to compare prices, because I just 
thought that now that I remember it, I’ll buy. In any case, it’s something that preserves for a 
longer period of time. 
 
Sara is also actively involved in student life, which includes attending parties and celebrating 
sometimes multiple times during the week. This occasionally results in an irregular schedule 
of days, as she tells to have partied “even somewhat too much lately”. Despite, Sara mentions 
one of her key life values to be healthiness though after not actively competing in sports any 
more, it has been left in a secondary part. This leads to exploring her consumption of vita-
mins, which follows rather much preventive reasons and provides relief for her conscience 
that suffers due to the athlete background. Indeed, through consumption of vitamins, she vali-
dates her unhealthy habits of eating. 
 
S: I’ve purchased these multivitamins sometimes, but I don’t eat them daily, because it’s like 
I take them if I remember or if I’ve eaten unhealthy. To cover for the Big Mac, multivitamins. 
 
Sara continues that she knows people who tend to avoid consuming medication, but because 
she has been sick so frequently since early age, she has been used to taking medication and 
therefore does not question consumption and tends to consume drugs rather much during the 
flu. Avoidance, thus, is not a key issue because she has formed a casual relationship with 
medication due to experiences and authorities that underpin trust. When asked what type of 
consumer of medicines she is, she depicts to be one looking for convenience and comfort, and 
consequently tells of a situation when her back was hurting terribly and for the cure used her 
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father’s muscle relaxants. Afterwards, Sara was told by her boyfriend that the particular mus-
cle relaxant product is banned in all other Northern countries due to causing cerebral hemor-
rhage, which despite did not scare her and consumption has occurred even after the infor-
mation. Sara tells of her reasoning behind the story: 
 
S: This was after I had used it, I have this “bird’s nest” [a Finnish phrase of an extremely safe 
place] image in my head that if it’s sold in Finland it’s ok. I don’t know how smart that is, but 
somehow a lot of people think that “It won’t happen to me”. That kind of thought that it won’t 
happen to me if it’s one of a hundred - it won’t be me. 
 
Trust, especially, is important to Sara because she does not like that corporations loosely use 
consumers’ private information. When asked about her trust towards pharmaceutical compa-
nies, she informs that it is not the brand or manufacturer, but rather the doctor and Finland 
that affect her as was evident from the prior story. 
 
S: Finnish people in general are like that we think that we live in this “bird’s nest” and no one 
can hurt us. And I think that with medicines it is the same thing - if a doctor prescribes me 
something, I won’t question if it’s bad for me. 
 
However, when asked if Sara purchases Finnish products she admits that price is a more im-
portant factor in her life situation although there is a willingness to support domestic busi-
nesses. In addition, when talking about usage of specific brands, she tells not to be brand loyal 
towards anything.  
 
S: I think it’s like this general way for everything, I have never had this “I have to have all 
Guess handbags” or anything. Or like, for example, with grocery stores that I would only 
have to go to S-market or K-market. I don’t have to buy specific stuff in everything, it just 
depends. 
 
This philosophy is also seen in Sara’s loyalty towards nasal spray, a product she is very fond 
of but has not become attached to any particular brand. She explains that throughout years, an 
especially close relationship has developed with this product, almost one of an addiction. 
However, the addiction only exists during the flu season and afterwards she could just forget 
about the whole product. Sara shares an intimate experience she had while consuming the 
nasal spray that well explains her attachment. 
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S: I remember I was dating this guy and going at his place, and I wondered what would this 
night be like because I had the flu and had forgotten my nasal spray at home, and I just pan-
icked. 
I: How did you experience the panic? 
S: Like I started wondering if I should search for the closest pharmacy and go get the spray. 
After many years, I had been used to putting it on when I have the flu and then go to bed. 
Then I’d sleep normally and wouldn’t have to wake up during the night. 
 
 
In this type of consumption, the medication acts almost as of a savior in rescuing her night 
and easing her symptoms. Another similar experience she maintains with a caffeine tablet 
brand called Cofi-tabs that her friend introduced to her. Sara recites that she takes caffeine 
pills if she has not slept enough and needs to take an exam, or wake up early for school; in 
other words, when “there is a feeling of the world ending”. After all, they are a more conven-
ient choice than coffee because her stomach does not handle coffee well. She remembers one 
memorable and emotional experience with Cofi-tabs, which saved her day. 
 
S: When we had broken up with Kari, I didn’t get much sleep and I had an exam the follow-
ing morning. I had slept for like an hour during the night. Then in the morning, my friend 
gave me a couple of these Cofi-tabs, maybe this is a single time that I remember the best, and 
it was the first time I used them. I thought that since I’ve slept so little it’s better to take a few 
pills than go there to doze off. 
 
 
Afterwards, when depicting what generates her becoming attached to a pharmaceutical prod-
uct, Sara immediately announces the functional benefits: that the product produces encourag-
ing feelings and provides relief, which is demonstrated in her various narratives. In addition, 
she explains that medication represents being able to live like the others, a normal life. Medi-
cines offer a path of handling daily tasks though she would feel herself sick, or being able to 
intensively exercise though there were symptoms of her asthma.  
 
S: It is this nasal spray again, it’s an awesome invention. Like it eases things, I wouldn’t like 
to go school when I would have the flu, but I wasn’t so sick that I would dare to stay at home. 
It eases daily life, you can have a normal life. It applies to other medicines as well: you can 
live like so called healthy people when you take medicines. You won’t let coryza bother your 
life. It’s good in that sense, deficiencies, like the flu, you can relieve symptoms and go to 
school.   
 
On the other hand, Sara prefers to avoid becoming addicted to products. It could easily hap-
pen with the nasal spray, after having her friend tell her that they apply it even after the flu. 
This arose questions in her mind and brought uncomfortable feelings, though she is very fond 
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of the product. However, when conversing about relieving neck pain, she mentions that it is 
either medication, exercising, or alcohol that provides aid, therefore placing medicines in line 
with the two activities she most enjoys: parties and playing sports. 
 
As a consumer, Sara describes to be the type that readily recommends products to her friends 
and also receives recommendations with great delight (Hess & Story, 2005). When asked 
what kind of influence her parents have in her consumption, she explains that they recom-
mend products to her. This might provoke usage, but in reality the impact does not differ 
much from her friends’. However, it is noteworthy that the relationship with her mother is 
more of a friend type rather than an authority.  Sara also tells that she has learned the price-
consciousness from her parents, and her disloyalty towards brands can also be seen as a quali-
ty shared by her mother. 
 
 
Sara’s key words: Savior, prevention, being able to act as healthy people, relieving con-
science, brand images, price-consciousness, functional qualities.  
Components of trust: Being sold in Finland, having doctor prescribe or recommend, having 
friends recommend. 
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Esa is a 25-year old male, who has recently graduated from the military academy and now 
works as an officer for the Finnish Defense Forces. Esa has always lived in Helsinki except 
for some periods during his schooling, is unmarried and lives alone in the center of Helsinki. 
Throughout his life, Esa has practiced both team and individual sports, including track, foot-
ball, dancing, and marathon running. He frequently tells his mantra to be when consuming 
OTC medicines: 
 
E: I never treat the symptom. I always treat the cause. 
 
Afterwards, Esa explains that he sees medication as something that facilitates pain manage-
ment, provides relief, and is in his words “a need-driven product”. Thus, he does not admit 
having strong brand relationships and stresses logical issues behind his purchase decision, 
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such as the price of the product. Despite, he does begin to talk about Finrexin, a flu medicine, 
which he tells to have grown especially attached to and has used since he was an infant. He 
even remembers the outlook of the package and promptly points out that it is not a product 
manufactured by Orion. But when asked about the relationship with the brand, he begins to 
rationalize and becomes uncomfortable. 
 
E: Now if I wanted to observe myself, I should notice that I have victimized myself like that 
and grown attached to something, then I should see if there is any reason for this kind of at-
tachment. I should re-evaluate my actions. 
 
Avoidance is a theme that keeps coming up in Esa’s interview quite frequently. When de-
scribing the consumption of painkillers, he stresses how medication is never the primary op-
tion, but how he rather rationally thinks of the situation as what causes the headache and 
could something else relieve it, such as drinking water or flexing neck muscles. On these 
types of other ways than medication he utilized the term “light tools”, whereas medication 
and surgery in his terms are "bulldozers". After trying all the “light tools”, if medication is 
still needed - as he says, befalls extremely rarely - Esa does not rely on modest doses.  
 
E: I took a lot of painkillers because then I knew, I did try to flex my neck, but I knew it 
wouldn’t go away just like that. In a way, like I already said in the beginning, you take noth-
ing or when you take, you take a lot. Like you would take booze during the weekend. 
 
 
As the above might sound slightly black and white, it well reflects Esa as his interests pre-
dominantly follow “all or nothing” style. In addition, he explains that when he finds some-
thing interesting, he does not yield easily until it is resolved. Persistence is the word that he 
uses when he describes his persona. Another issue that characterizes Esa is his highly logical 
thinking and explaining that is already visible in his tone of voice when speaking. As Esa ver-
bally walks through his visit to a pharmacy, he depicts: 
 
E: I usually know what I want, or/and I have a prescription. If I have a prescription, I’ll take 
the queue number and get in the line. I answer questions if there’re such and I pose them if I 
have any. Afterwards I probably leave the pharmacy. 
 
 
This effortlessly escorts the conversation to another theme following Esa, impulsiveness. Esa 
defines that one of his key life values is to do what he desires. He firstly begins to describe 
this as individualistic behavior but quickly starts to explain how completing something today 
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instead of tomorrow is what he indeed implies to. This is because he himself realizes that im-
pulsiveness and his stressing of rationality in all his actions are in contradict, and thus threat-
en his logicality. To explain, he utilizes the word “the golden middle path” of his own rela-
tionship between being impulsive and at the very same time rational.  
 
Impulsiveness shows in Esa’s consumption in a way that if he wants to purchase, in his 
words, a motorcycle, he will readily execute it. But on the other hand, when narrating about 
purchasing a new computer, he stresses how he first comprehensively compared the different 
options, did not invest in the most expensive one and when decided, closed the computer 
without saving the plan and slept over night. A few years back the situation would have had a 
disparate ending: he would have speedily purchased the computer because otherwise he had 
known that the money would be vanished to other causes rather quickly. Esa reasons this by 
pointing out that now that his earnings are steady, his consumption is not as hasty as he 
knows cash flows will not be ceased. He adds that in life, he thinks that if one truly wants to 
do something, they should perform actions today instead of tomorrow. However, he does not 
imply anarchism or such with this philosophy. Rather, it has to do with expressing his persona 
and being true to himself. Here he begins to talk about his hobby of dancing, which for a 
Finnish man and someone in particularly working in the military could be somewhat peculiar, 
according to Esa. 
 
E: If I wanted to do something, like practice something or go somewhere, it is my decision, 
no one can tell me what to do. For example, I’m a soldier who dances and that’s something 
that always puzzles people. As it usually would be, or for most people, to have martial arts as 
a hobby or so on. It would be much more stereotypical. But I like it [dancing] and that’s why I 
do it. Or if I wanted to travel somewhere out of Finland, well I’ll just go. I think that if I want 
to do something, I’ll do it and I won’t have to look back and feel sorry that I didn’t. 
 
Esa frequently expresses doubts about the power of the pharmaceutical products and in sever-
al situations mentions placebo. Even when he envisions his favorite product, the Finrexin flu 
medication, and explains how committed he is to the brand that results him even not looking 
at the price, his final comments are: “Placebo works with it”.  In addition, when considering 
Duact that is a flu medication provided by the military, Esa says that for him it does not work 
because of the lack of trust. 
 
E: Apparently my trust towards medication is too weak that placebo doesn’t work, or my 
body resists it. 
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When asked to elaborate his thoughts on placebo, Esa presents yet another logical process. 
Namely, the effect of a drug results from him reading the product caption and then knowing 
how the medication affects his body. This, on the other hand, leads to his trust towards the 
product to found. Hence, Esa wants to be in charge of building his trust and therefore uses 
placebo as a primary shield to question. However, the philosophy is not only restricted to 
pharmaceutical products, but other health products as well, such as Activia yoghurt.  
 
E: Is it so that when you take it, your stomach starts to act better because you take it and it has 
active ingredients, or because you start to watch your diet and so on, and then your stomach 
gets better?  
 
Because of the placebo issues he is also continuously looking for proof that the medication 
functions, and to him it is important to see that the product in fact works instead of hearing it 
from someone else. This is also related to his thought of him being in control of his decisions 
and actions, because trust needs to be formed by the support of his own findings and not out-
side influence. He tells of an incident of being very sick and having to stay in the garrison 
hospital to be treated. There he was offered “Burana or some other ibuprofen” for the severe 
fever. 
 
E: I remember when the nurse came in and said to take clothes off because soon I would start 
sweating a lot. I wasn’t naked, I don’t mean that, but with my t-shirt and combat pants on, 
then suddenly the sweat came, I remember that. Then you just realized that maybe this really 
works. Or for the fever in general, it lowers that. That I realized. I could establish that it works 
due to the fever. 
 
Though Esa works in the military, patriotism is not the value he brings up himself. Being 
Finnish he explains is “a value by itself”, but it does not strictly guide his consumption deci-
sions. If the products are priced the same, Esa selects the Finnish product, but if the domestic 
product is “expensive and crap” he will rather purchase the good and foreign one. Neither 
does he regard pharmaceutical companies badly, but rather defines that he is not ignorant and 
accepts that “money rules the world due to capitalism”. Here he also expresses another com-
ponent in building his general trust towards medical companies. 
 
E: Maybe I’m naïve or not, but I do trust that they [pharmaceutical companies] do their things 
right, because if they made crappy medicines, pretty crappy business it would be if people 
died because of their drugs. 
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After this, Esa mentions to trust that in Finland risks are “under control”, which consequently 
also consolidates his trust. In addition, he iterates that trust along with the placebo effect is 
founded after reading the product caption, which tells what kind of ingredients there are and 
how they affect, again stressing that trust is something he develops after seeing and experi-
encing. Also, he does not regard OTC medicines risky, because “you can buy them from a 
pharmacy”. To Esa, the basic corner stones of trust thus seem to be the sales environment, 
product labels, Finland, and the market mechanism.  
 
The final issue, which Esa becomes extremely passionate about, is the advertising by pharma-
ceutical companies. When looking at Orion’s corporate advertisement, Esa tells that it is ap-
propriate on the other parts except for the military medication bag, because it is not believable 
since it is too petite for a doctor. Also, he tells the first impression being “taking advantage of 
patriotism”, which arises negative feelings. In addition, when viewing the web advertisement 
of a burping wolf, he wonders why the pharmaceutical companies always exercise only two 
strategies to present their products: either being “over appropriate” or “using crappy humor”, 
both of which cause him to feel ashamed on behalf of the companies.  Authenticity and origi-
nality (Malär et al., 2011) are qualities Esa would appreciate with advertising. 
 
I: What do you think about the advertising by pharmaceutical companies? 
E: I should probably first see these ads myself, before I could tell if I were ashamed, ashamed 
on behalf of them, or like what the crap is this now. Probably as it would be directed towards 
Finnish people, it would have some kind of yellow hayfield with a blue-eyed, blonde-haired 
girl in a white dress running around and coughing a bit. Then she’d be given some kind of 
medication and a company logo would come there and it’d say “the healthiest Finns since 
year x”, and you’d be like oh well that was an original theme. 
 
 
 
Esa’s key words: Need-driven usage, avoidance, treating the cause, placebo, authenticity, 
individualism, logicality. 
Components of trust: Pharmacy, Finland, having proof and being in charge of developing 
trust, capitalism. 
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Lisa is the mother of Sara. She is 52 years old and lives in a smaller town about 100 kilome-
ters away from Helsinki. She holds a master’s degree in economics, but has recently had to 
leave her job due to severe health issues and has applied for early retirement. Before the 
health problems, she was employed in career counseling and tells of her thoughts on work 
back then: 
 
L: I remember back then when I talked to my classmate about career goals and all, and I have 
always had this “un-business-student-like” attitude as to me it’s always been important to do 
something that makes me happy. So that life would be happy and balanced, I don’t reach for a 
career in this sense. 
 
 
Along with having children, falling sick has rearranged her life values as she nowadays tells 
to enjoy “the little things”. Despite, being healthy has always been the most important value 
to her and also having her children and husband healthy. Children, especially, she stresses to 
be the most important matter to her, which is indeed shown in her very close relationship with 
Sara. Another key value to her is to be able to help others. This utilitarian attitude has been 
shown in her choice of career, too, which she depicts offered the possibilities to “really help 
people”.  
 
The need to provide aid and care along with her role as a mother also affects Lisa’s purchase 
behavior of OTC medicines. She narrates that during the years Sara actively pursued sports, 
she tended to purchase “magnesium and other vitamins for athletes” for Sara, and that she has 
advised her to take iron tablets if there are experiences of fatigue during the period. In addi-
tion, Lisa tells to worry of her son, who is in Japan for student exchange, and that he might 
not be leading the healthiest life there. To take action, she was about to include a multivitamin 
product “half-joking” in a Christmas package that contained his clothing and other things. 
During this story, she repeatedly refers to the word “caring” and tells of her behavior: 
 
L: I thought that the mother would care a little bit that the son gets vitamins. Because if they 
just party there and don’t eat so well. 
 
Consequently from her permanent sickness, Lisa is no stranger to drugs, neither prescription 
nor OTC. In her life, medication plays an important role as it helps her to manage through 
daily tasks. When talking about medication, however, she regularly uses the word “useless” 
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or “purposeless”. This is because in her mind no one should consume drugs for “no purpose”, 
and consumption should only occur when it is absolutely necessary. Lisa also thinks of the 
pharmacy as a place where they do not sell products “purposelessly”. Namely, to her pharma-
cy is an institution that is reliable, truthful, and maintains the people’s interest as top priority. 
She remembers an example from before that took place while shopping for body lotion. 
 
L: And it was just this pharmacist who told that for me that’s an excellent facial moisturizer 
and that “you don’t have to buy those more expensive ones”. This is just what I meant that 
they would not just start praising the most expensive one, which you should by no doubt pur-
chase.  
 
 
When Lisa discusses trust towards drugs, it appears that the pharmacy is a major component 
creating it. According to her, the pharmacy does not sell any “non-sense” and the product 
being sold in a pharmacy is “a guarantee of quality”. Further, when talking about if medica-
tion were available in supermarkets, she tells that if they were exactly same products sold in 
pharmacies, she could as well buy them elsewhere, but otherwise operating in a pharmacy 
environment seems more reliable to her. This could be due to her close relationship with a 
local pharmacy, which she describes as “I’m pharmacy-loyal, like my mother”. In this par-
ticular pharmacy, they have her product information on the computer and there is a pharma-
cist that is “extremely helpful and friendly”. In addition, her trust towards the pharmacy has 
grown through experiences with the pharmacist revealing that certain medicines should not be 
used simultaneously.  
 
L: I heard it from the pharmacist and not a doctor that “did you know Panacod does not work 
as well when you use this other medicine?” I was just like no wonder it doesn’t work as effi-
ciently as it could. Then I told the doctor and they said, “yes it’s not that good”. Then once 
the doctor had prescribed me a painkiller product they told me in the pharmacy I can’t take 
since I use this other drug. 
 
 
Having proof and experience is another theme that belongs to Lisa. As she talks about her 
consumption of OTC brands, she narrates of a vitamin B product that she was recommended 
by a doctor and began using. However, it was not the doctor’s word that resulted in her to 
trust the item, but blood tests that visibly showed her vitamin B levels having risen. 
 
L: I trust their power, especially the vitamin B product after seeing it in fact raised the levels. 
The calcium product it’s hard to say, but in a way I do believe the bones would maintain. I 
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have this trust towards these medicines that they work and they will benefit me. That they 
wouldn’t be complete non-sense. 
 
Seeking for proof was also seen in how Lisa argued for the pharmacy being reliable: after 
having the pharmacist recommend her less expensive products and therefore demonstrating 
not to simply sell products but to view her needs and values important. In addition, when tell-
ing about a heartburn product that she is especially fond of, Pepcid Duo, she mentions that it 
is due to the product qualities, especially the efficiency of the product and that it affects im-
mediately, not after a while that some other products do. Also, after trial she has established 
this OTC product as powerful as another prescription heartburn medicine, which has fortified 
her trust towards the brand even more. Regarding this medicine, she also tends to avoid taking 
it as long as she can, because again she averts consumption of medicine “for no purpose”. 
 
Lisa values her OTC medicines to be easy to administer, implying a functional product quali-
ty (Hess & Story, 2005). She commences a discussion on gastrointestinal medicines and how 
she prefers a product named Laxoberon, because it is in a tablet form instead of liquid, which 
creates it convenient to administer and consume with her prescription medication. Here, she 
stresses the easiness of taking the product. 
 
L: I thought I’d try those peculiar-looking little pearls [tablets]. Now when I think, I’d rather 
take a few of those pearls instead of having to measure the mixture to a cup, so maybe the 
easiness is one thing there. 
 
L: I have my medication there, my dosette, and also the Laxoberon bottle. Then I might re-
member when I take my evening medication that “Oh I’ll take those too”.  
 
 
What indeed affects Lisa’s trust towards drugs, in addition to that it is sold in a pharmacy, is 
that a doctor recommends it to her. Moreover, the product being sold in Finland to her is “a 
guarantee of quality”. Therefore, the manufacturer holds a diminished role in her mind, as she 
tends to look at the prices more than who manufactures the product. She also points her vast 
trust towards the supervision in Finland and that the medicine would not be allowed to enter 
the Finnish market if it was not properly working. Buying a foreign product for her is not a 
problem, unless they are natural remedies in which case she prefers domestic products. 
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L: I think it’s especially important to be a large employer in Finland. It’s important, well the 
product for sure could be manufactured by someone else if the same raw materials would be 
used. And of course the products could be done in some place else, there would naturally ex-
ist quality inspection. 
 
 
 
Lisa’s keywords: Easiness, effectiveness, avoidance, price-consciousness, pharmacy-
loyalty, utilitarianism, functional qualities. 
Components of trust: Pharmacy, recommended by the doctor, being sold in Finland, having 
proof. 
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Milla, a 25-year old postgraduate of business administration, also comes from Helsinki. She 
lives alone near the city center and is about to finish her degree. She is a vegetarian and holds 
ethical and ecological values important. When she explores her consumption of OTC medica-
tion, she says to avoid taking the medication for a headache as long as she can and frequently 
takes only half of the tablet. To this behavior she has multiple reasons. Firstly, she does not 
want her tolerance to grow towards medication. Secondly, her father’s example has taught her 
not to consume drugs for “no purpose” and thirdly, she has shared an unpleasant experience 
with analgesic drugs after a surgery. 
 
M: I came home and they told me to take 1000 mg at once, and I would take like 250 mg be-
cause it was enough. After that I’ve become a little bit more careful that I will only consume 
the drugs I know, and I’ll take small doses. Because I hadn’t really realized that you could 
take enormous amounts and how bad of a tolerance I have. Afterwards you probably realize to 
be more careful. And then I’ve taken just something I know. Like Burana. 
 
 
To Milla, it might be her parents’ example of supporting Burana or this particular event that 
has formed a contiguous bond with the brand. Though she has unpleasant experiences with 
the product of administering too much of it and feeling ill, it is not the brand’s fault, as she 
defines it. When talking about Burana, namely, she frequently uses words such as “safe”, 
“familiar”, “trustworthy”, and even admits an emotional bond towards the brand after becom-
ing accustomed to. When asked if she preferred consuming the less expensive, unbranded 
pain medication, she explains that even though her parents have Ibumax or other inexpensive 
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product stored, she will always take Burana. This is because experience has taught her what 
kind of amount to take and how long it will affect her body. In a sense, Burana has become a 
partner to Milla after familiarity and watching family members consume the brand. Also, she 
lists that because it is such an old medicine, the recipe probably will not be altered any more 
as it has been discovered to work. At this point she does not experience the price difference, 
as her consumption tends to be minimal. 
 
M: I don’t always know about each drug who manufactures it or care to find out, but with 
Burana you know that it’s Orion. I don’t know if I think about it, but in a way, it’s Finnish. It 
would be a different thing if I consumed a lot of it and it was very expensive. In the end, the 
difference won’t be much because I buy a package or two in a year and then I’ll rather support 
a Finnish company. 
 
Another important theme for Milla, deriving from her life values of ethicality and ecological-
awareness, is the animal experimentation the pharmaceutical companies conduct. Due to a 
school project where she investigated the responsibility of pharmaceutical companies, she has 
gained profound information of this business and companies, which has disturbed her. She 
stresses how because of this she also prefers to consume Burana, since it is most likely not 
tested as much as new medication. Though learning about the animal testing and how much 
the companies conduct those, it unexpectedly did not affect her views of the pharmaceutical 
business because to her “health comes first”. Despite, it did influence her choose of brands, 
also in the corporate level. 
 
M: When I went through them, it left certain names in my memory, like what are the five big-
gest and then Orion. Then I probably always try to look for it [drug] to belong to a company 
in the list of the top five biggest. I don’t know if it really matters, but to me it brings safety. 
Because they have well-researched medicines and they can’t screw it up. 
 
Milla also lists one clear reason she consumes Burana and other Orion’s products, such as 
Ceralan body lotion, that they are manufactured by a Finnish company. In frequent cases 
when she depicts her consumption of Burana she tells that a primary reason is that it is Finn-
ish. However, it is not only this that forms her trust, but as told that the manufacturer is a 
large company and that the medication is recommended by a doctor, even if it was an OTC 
product. Doctor, to her, is an important authority and she even tells that if a budget product 
was offered to her by the pharmacist, she would not trade because having someone prescribe 
her the product forms feelings of safety, since the responsibility is thus the doctor’s, not her.  
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M: I do feel that with medicines it is good that it is a familiar product, or someone recom-
mends it. Like a doctor says that this is especially good. Even if the doctor didn’t write a pre-
scription and it was an OTC product, I would still go get what they recommended. 
 
The doctor is not the only authority Milla confirms affects her selection, but her parents main-
tain a considerable role in her choice of products though it is not necessarily conscious behav-
ior. When she depicts her usage of Burana, she describes how it was always the brand pur-
chased at her childhood home and even brings feelings of “home”. In addition, Milla feels 
that medicines especially are a product that is affected by her parents’ consumption because 
compared to clothing or such, she would not necessarily support the same brands.  
 
However, when asked how she would act if Burana was not available in one particular phar-
macy, she says to select some other, well-known analgesic medication brand, such as Panadol 
or Aspirin. Her loyalty, therefore, is not extremely deep towards only Burana, but rather ex-
ists in the top brand category of painkillers. However, Milla quickly points out that Burana 
not being available in a pharmacy has never occurred and therefore it is only hypothetic. Nei-
ther is the efficiency of the drug important to her, as she mentions that simply the improved 
functional qualities would not result in a switch of the brand to a bargain one.  
 
The brand bond with Burana results Milla’s price tolerance to expand (Hess & Story, 2005). 
However, it is not only with analgesic medicines that she experiences such thoughts with, but 
also body lotions that Orion manufactures. Ceralan is a brand she purchases because it is the 
most effective one for her skin and she does not rely on “the market products” with her skin-
care because they do not moisturize as efficiently as the products sold in pharmacies. Thus, in 
terms of body lotions she stresses more of the functional values whereas with Burana it was 
the more abstract and personal connections that affected. However, she does mention that 
familiarity, again, guides her consumption of lotions as well. 
 
M: You easily go with what you’ve purchased before. It is like easy, you don’t have to study 
and see which kinds of issues this affects and if it is good. And with lotions you don’t have to 
think about if it is effective enough. 
 
Milla also assures that she always has pain medication with her, in her purse and at her home. 
Especially if there were occasions when she would proceed from work to see a movie, she 
tells to already prepare by ensuring there is Burana available due to the neck pain of staring at 
a screen “for 12 hours or such”. This follows from an experience she had after going to the 
  
 68 
movies after work and having to depart due to the pain. Despite the preparing, she describes 
her consumption of painkillers to be more avoiding than frequent, and that she only uses 
painkillers if she absolutely has to do something. 
 
M: Of course if I have to do something, like take an exam, then I’ll take it [drug], but if I 
don’t have anything that I have to do, I’ll rather try to rest because then I know what my real 
condition is. Because otherwise you’ll feel yourself healthier than you are and you don’t real-
ize that it is the medication that makes you feel good, not because you’re well. And then you 
easily go do too much. 
 
 
The final issue Milla addresses is that she has started to pay attention to who manufactures the 
medical and cosmetics products she uses (Shamma & Hassan, 2011). When looking at the 
advertisements, discovering the manufacturer sometimes evokes feelings of surprise; for ex-
ample, when it is a company she would not believe manufactures those types of products, or 
feelings of being “tricked” if the company reveals to be a subsidiary company of someone 
else’s (Malär et al., 2011). 
 
M: Well maybe you could feel a bit conned if you realized afterwards that it’s someone’s sub-
sidiary company and you’ve thought it’s some other company. Maybe that is why with medi-
cation, I like to know who manufactures it, to me it’s more honest, if you can say so. 
 
 
 
Milla’s key words: Carefulness, brand loyalty, safety, familiarity, avoidance, parents’ ex-
ample, preparing, transparency, corporate brands, ecologic and ethical values. 
Components of trust: Brand loyalty, having the doctor recommend, being manufactured by 
a Finnish company, pharmacy, large corporations. 
.
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Though the experiences, stories, and backgrounds varied quite an extent, the interviewees 
share certain similar themes that may be summarized here. In addition, it is interesting how 
differently they argue for consumption and what in fact affects their trust. The first, most 
agreed theme was the avoidance of medication. Most of the consumers namely want to avoid 
taking medicines as long as they can, due to various reasons. Examples would be the fear of 
tolerance growing, seeing this type of consumption useless, or being afraid of a developing 
addiction. On the surface, medication represents a need-driven, symptom-reliving way of 
handling sickness, or in Esa’s situation, treating the cause. Lisa and Milla even distinguish 
Finnish people from other cultures where medicines are consumed with lighter reasons, such 
as preparing for an upcoming cold with antibiotics. As Lisa phrases: “We [Finnish people] are 
more aware of these things”. 
 
However, though Esa stressed treating the cause instead of a symptom, this was not a thought 
shared by all other interviewees. Mika, for instance, tends to use extensive amounts of analge-
sic medication during the flu to diminish the feelings of the sickness and to be able to act 
normal. Sara follows this behavior with Cofi-tabs as she takes them to not feel herself weary 
instead of resolving the problem by sleeping enough. As Esa tends to use the natural or 
“lighter” tools, Mika and Sara are more eager to take the pain medication sooner, though they 
as well emphasize not to consume drugs for a minor headache. Furthermore, both males iden-
tify their consumption of painkillers to be heavy, if it takes place. Milla, on the other hand, is 
the most careful consumer of them all since she avoids taking even a whole tablet of a pain-
killer for a headache due to an unpleasant experience of being administered too much of the 
medication and losing control. This also results her not taking painkillers during a cold be-
cause she does not want to feel herself too healthy, but to control her real state. Milla also 
tells to “over watch” herself when she trials new medicines. 
 
When Sara and Mika talk about taking vitamins, it follows the theme of prevention. Through 
consumption of vitamins, they can cover for their bad eating habits and validate unstable life 
and partying, in addition to protecting themselves from becoming sick. They do not necessari-
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ly trust that the vitamins would prevent from catching a disease, but the products act more as 
empowering means for their unhealthy lifestyles and provide relief for their conscience.  
 
Supplements are also a method of expressing motherly caring, which Lisa showed in her ex-
perience of purchasing these for her son, who would probably exercise unhealthy habits dur-
ing his student exchange. When she talked about her children, she did not mention to provide 
them painkillers or other medication from the pharmacy, but iron tablets, lotions, and multi-
vitamin products. As her children have both recently left their childhood home, it is still im-
portant for Lisa to indicate care and through purchasing these products she demonstrates that 
their health is a priority, also expressing a life value close to her whole family. 
 
Another important role OTC products play in the consumer’s mind is the Savior. With Mika, 
this was seen in the pain remedy saving his vacation though he had a terrible flu. Sara, on the 
other hand, was able to take an exam despite the break-up she experienced just the night be-
fore and the resulting inadequate sleeping. In addition, Sara carried the nasal spray with her 
all the time if she had a cold, and not having it with her caused a panic. Milla tended to pre-
pare for the coming movie after work by reserving painkillers beforehand, because otherwise 
her neck pain would force her to leave the movie theater. With this type of behavior, however, 
Milla emphasized the expression having to do something. To Lisa, this role of medicines is 
evident as they help her with her sickness and treat the symptoms. In addition, Lisa described 
that when she was younger, she used to take Burana before entering the nightlife, because it 
would ease the following morning. Sara even defines drugs being a key to a normal life and 
allowing to function like the healthy people do. In this sense, the consumption follows much a 
preparing way since some of the consumers already know what is coming and from experi-
ence store medicines for this purpose. 
 
Consumers also admitted to use certain brands or products after becoming familiar with them. 
For Milla, in particular, this was an important factor as it had turned her very brand loyal to-
wards Burana. Consuming Burana evoked feelings of familiarity and even cozy, resembling 
her parents and childhood home where the product is used. As a result of habit, Milla had 
learned what kind of dose to take and how long the product affects, creating a strong partner-
ship with the brand. Mika and Sara shared the same feelings with a nasal spray product, 
though Sara did not have a particular brand to buy. Through using the product already as in-
fants they had developed close relationships with it, which vitalized during the flu season and 
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contained stories of their mothers, who in both of the consumers’ lives play an extremely im-
portant role. Esa shared this type of experience with Aqualan L body lotion and Finrexin that 
were used in his home. Both relationships resulted him to not look at the prices any more or to 
compare the products. 
 
There were dissimilarities in the consumers’ life values of the sexes, as both males stressed 
individualism and authenticity whereas females had softer values such as being healthy and 
ecological. Further, Esa and Mika both emphasized the need-driven side of OTC products, 
which Lisa, Milla, and Sara expressed more in a sense of “not consuming medication without 
a purpose”. When looking at brand relationships, Esa carried a close relationship with Finrex-
in and even admitted fondness, therefore overruling Fournier’s (1998) thought of males not 
defining their emotions easily. This was the same with Mika, too, regarding the nasal spray 
that he admitted being addicted to though there was no disease present. Both male consumers 
shared long relationships with their favorite brands and the type that was already built in 
childhood and contained their mothers in the stories.  
 
To all of the interviewees the pharmacy represented a reliable, safe place to purchase the 
products from. Though some experienced it not such a pleasant purchase environment, it was 
a place where they would obtain expert help for their need and also a relief. The setting thus 
emphasizes the need-driven role of the OTC products, too. As in their minds pharmacies do 
not sell “purposeless” products, neither should the products these stores sell be used for “no 
purpose”. I will analyze the role of the pharmacy as a purchase setting further in the next 
chapter. 
 
The life values consumers had seemed to also follow their purchase and consumption habits 
of OTC products. Lisa, who valued her children and caring for them along with health, de-
scribed how she would purchase products and offer them to her children to look after. Sara 
followed this style in consumption of vitamins, which she used to cover for her unhealthiness, 
and thus pursued the life value of health. Ethical-awareness and avoiding medication that 
would be extensively experimented with animals were important factors for Milla, who also 
valued domestic products and ecological values. Mika and Esa both identified impulsiveness 
and individualism important for them. This restricted them from becoming attached to brands 
or buying “brand products” and explained their consumption being price-conscious. Despite, 
they both shared long brand relationship they had not thought of and became uncomfortable 
  
 72 
when admitting that they do not evaluate the price when purchasing these products. In this 
sense, Fournier (1998) might be correct that male consumers are not eager to admit their feel-
ings towards brands as openly as females, but it is still important to notice that these relation-
ships exist though they would not be discussed directly or preferably. 
 
The final, central theme Lisa, Mika, and especially Esa share is having proof that the product 
functions before trust can occur. This happens after using in Esa’s case pain medication and 
in Lisa’s case the vitamin B product, and experiencing themselves the products’ visible ef-
fects. To Esa, having a physical reaction as a result of the medicine was enough as for Lisa it 
was a blood test that unveiled her vitamin levels having risen. Mika also tells that his trust is 
constructed after having watched the product affect him, which occurred with Ibusal in Lon-
don. Milla, on the other hand, does not emphasize the efficiency of the product, but to her 
trust and being familiar with the product are more important, though with moisturizers she 
values the functional benefits.  
 
 
 
 
 
.
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Chart 2: Reasons for consuming OTC products 
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After describing what evokes consumption of medicines, I will now analyze how the consum-
er trust is built and discuss it through the viewpoint of the purchase environment, country of 
selling, and the role of manufacturer. As the prior section discussed the consumers’ experi-
ences in detail, I will now concentrate on depicting the larger phenomena. This is also neces-
sary to support the upcoming, brand relationship section since trust seems to be a vital com-
ponent of a successful consumer-brand relationship. This section will move a step further 
away from phenomenological methodology since I seek to develop certain general themes and 
also answer to the third research question of what constructs trust. 
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Probably the most unanimous and positive thoughts the interviewees shared were on the role 
of the pharmacy when purchasing medicines. To all, the pharmacy is a safe place to purchase 
medicine and one of reliance. However, the consumers had varying levels of trust regarding 
this institution. Firstly, as Lisa would proceed as far as defining herself pharmacy-loyal and 
describing how in pharmacies “nonsense” is not sold, Mika stressed how he would purchase 
the recommended products only if the pharmacist argued well enough for them. In addition, 
Mika defined that while he was living in England, the pharmacies were much more conven-
ient as one could also purchase candy and food there, and the shelf placement of drugs was 
more lucrative. Tuuli also joined this thought as she told that even the products resemble what 
the purchase environment is like: dull.  
 
Pharmacists seem to play a key role in building consumer trust as do doctors in both recom-
mending and prescribing the products. In particular, Esa told how pleased he is to receive help 
from the pharmacists, though he would not necessarily need it. He even mentioned that if his 
favorite brand were out of stock, he would rely on the pharmacist recommending another, 
presumably good product. Lisa stressed that she is extremely delighted that her favorite 
pharmacy keeps records of her purchases in the computer and the information is easily 
reached. She also told of an amiable pharmacist, who was always ready to help her and knew 
everything about OTC products, another reason why she would return to the particular phar-
macy time after time. In addition, when Mika depicted a situation he bought vitamin D from a 
pharmacy, he told how he would first ask the pharmacist to come along and present him the 
  
 74 
various choices, then decide. Though he had used the product and even defined his life value 
to be individualism, the pharmacist still maintains a key role in convincing him to purchase. 
As told in his consumption profile, he would even go as far as leaving the pharmacy if the 
service did not meet his standards. 
 
When discussed whether the consumer would be willing to purchase their OTC products from 
grocery stores, differing opinions arose. Lisa is the most negative towards this transmission, 
as she fears that then children would be able to purchase these products and that the general 
tendency to use medication such as pain remedies would lower. However, she does admit that 
if the products were ones sold in pharmacies and familiar ones, it would not matter, again 
stressing the importance of the pharmacy creating trust in her mind, also in the product level. 
To Mika, this would be a change preferred very much as he would like to see the pharmacies 
being open until late hours and to have an environment of more interest.  On the other hand, 
he defines as well that his purchases of pharmaceutical products are “done with sense”, so the 
color of the package does not consciously matter to him. Tuuli joins here by saying that she 
would like to purchase her products from a supermarket, too, and that in the pharmacy one 
does not experience feelings of “Wow, this is a new product, I want to purchase just this!” 
She tells that in the pharmacy, the products are not beguilingly placed and that it is a “clini-
cal” place, the adjective used by Mika as well. On the other hand, Tuuli claims that she is 
pleased to pay more for a cosmetics product that is sold in a pharmacy due to it probably in-
cluding less preservatives and color ingredients - a thought that could be biased. 
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In addition to the importance of the pharmacy, the consumers felt it is the homeland that cre-
ates trust. The consumers had explained to themselves that the products are extensively con-
trolled and the Finnish regulation ensures that there are no low-quality medicines on the mar-
ket. This is a thought somewhat biased when considering the narcolepsy incident just a few 
years back, but the consumers seem to have forgotten about it. Moreover, Tuuli tells that she 
purchases Ibusal not only because it is the least expensive one, but it is also manufactured in 
Finland, which she had read somewhere. Milla goes even further in defining that the pain 
medication brand must be well known and something she is familiar with rather than simply 
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being manufactured or sold in Finland. Though to her the country of origin plays an important 
role, she would still not use Ibusal or other budget products simply because they are domestic.  
 
When the consumers are asked whether it is the country of selling or manufacturing that con-
vinces them, they do not seem to place much importance to the manufacturing side. Lisa ex-
plains that to her it is more important that the company employs people and conducts R&D in 
Finland than that the medicine would be manufactured exactly in Finland. She trusts that 
someone else could manufacture the medication as well if the same raw materials and proper 
instructions were available. If the manufacturing were done in Finland it would not affect her 
decision as much as the price. She mentions, though, that if there were two products priced 
exactly the same and the other one was manufactured by a Finnish company, she would take 
the Finnish one, a thought shared by Esa, Sara, and Tuuli as well. 
 
The consumers’ trust towards the country of selling extends as far as even utilizing prescrip-
tion medication stated harmful in other countries, consuming a family member’s prescription 
medication, and using products that are outdated. In Sara’s case, she had told herself that it 
cannot be harmful if it is sold in Finland and that she could use her father’s muscle relaxants 
because “in Finland everything is safe”. Tuuli specified that she did not care that the Bepan-
then lotion had expired a long time ago, because it could not harm her. Regarding trust in 
medicines being safe, Mika would go the furthest by using Tylenol that is not even sold in 
Finland and was supplied to him by his friend. This could denote that trust is not simply de-
veloped due to the drugs being sold in Finland, but rather generated due to the mindset that 
exists among the Finnish people in terms of “we cannot be harmed”. 
 
The reason behind the low importance of the country of manufacturing could be because the 
consumers do not necessarily know about the nationality of the pharmaceutical companies 
and their trust is hence composed of other reasons. Sara, Tuuli, and Lisa were not sure if Ori-
on is a Finnish company, and Esa as well as Mika did not even remember the names of their 
favorite brands. However, they recalled the exterior features of the package and would de-
scribe them with detail. In addition, there was confusion with the brand names consumers 
would purchase, as Ibusal and Ibumax would be mixed as well as Multitabs and Multivita, 
and various other vitamin products. All of this shows that there is a growing need for better 
name developing, differentiation, and brand building along with spreading knowledge of the 
corporate values and origin to build trust that is based on the manufacturer. 
  
 76 
O"3"8 B$).&;-).;?.+$).(;&:;&%+,;/.
 
The role of the manufacturer seemed to have a minor place in the consumers’ minds in creat-
ing trust. As written above, the consumers were not familiar with the pharmaceutical compa-
nies and when showed the advertisement that told Orion is nearly 100 years old, all of them 
were surprised. This, however, evoked very positive feelings in the consumers. Regardless of, 
they did not feel that the advertisement would indeed speak to them, though they found the 
information interesting. Tuuli and Esa also were rather upset about the commercials that 
would joke about sicknesses and felt that the pharmaceutical companies should develop their 
advertisement in a fashion that was neither too serious nor would jest about uncomfortable 
illnesses. Esa also accented that his favorite brand Finrexin is not manufactured by Orion, but 
neither did he know who manufactures it, which was also the situation with Mika and Na-
solin. When asked how Esa knew it, he would remember that the package did not include 
Orion’s logo, implying that consumers do note the corporate brand’s communication at least 
to certain extent. However, though the vitamin product Calsorin D3 is currently much adver-
tised in television with the corporate name stressed in the advertisement, Lisa did not know 
who manufactures this product, which she shares a rather close relationship with. 
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The final section of the empirical part will unveil the brand relationships the interviewees 
shared with OTC products and explain how these have been constructed. For the upcoming 
discussion and theoretical analysis, I will use Fournier’s (1998) article already here when de-
scribing the brand relationships and thus elaborate the first and the second research questions. 
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By using Fournier’s typology of consumer-brand relationships (1998), the interviewees’ rela-
tionships with OTC brands may easily be understood and further examined. In the following 
page, there is a table summary of the respondents’ brands and their categorization according 
to this. However, certain brands were discovered to contain qualities of two or more relation-
ship types, which made the division challenging. Moreover, the relationships the consumers 
described had once contained attributes of a certain brand relationship and currently another 
one’s. No brand relationships characterized as Dependencies, Secret Affairs or Enmities were 
found. 
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Brand relationship type Case examples  
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Partnerships 
- ;/)&!B%+-.C%+!DE@)-(+.-!21!(-#/(FG!
- =%/)&!H)$/2-%+!,I!:!J%()*%+!A!5-)+7!
- >%K)&!L)/2$%+!
- "##$%&!A.@)+(3.+!
Marriages of  
Convenience 
- =%/)&!/M%(?3!(2!=2/.?!)+7!2(3.-!3.)-(5#-+!5-)+7/!7#.!(2!N.@?%7!
7#2!)$M)6/!5.%+0!2#(!21!/(2?K!!
- >%K)&!"6$.+2$!D?3)-)?(.-%/(%?/!21!)!?2#-(/3%@/!)/!M.$$G!
Enslavement - =%/)&!#/.!21!N)+)72$O!-./#$(%+0!1-2*!3.-!+2(!5.%+0!)5$.!(2!#/.!!
A#-)+)!!
Avoidance-driven - =%/)&!N.@?%7!7#2O!?2+/#*@(%2+!7.-%J%+0!1-2*!/M%(?3%+0!L.C%#*!
Courtships - 8)-)&!H21%P()5/!
Fling - >%K)!)+7!"##$%&!<?2!?-.)*/!!
- >%K)&!Q+%K##!
Casual Friends / Buddies - ;/)&!'2$()-.+!!
- >%K)&!!'%()*%+!A!)+7!,!@-27#?(/!
- "##$%&!>#$(%()5/!
Compartmentalized  
Friendships 
- 8)-)&!9?.!5)0/O!A.@)+(3.+O!)+7!95#*)CR95#/)$!
- =%/)&!=)C25.-2+!
- "##$%&!'%P8%5$%+!
- >%$$)&!H.-)$)+!
- >%K)&!95#*)CR95#/)$!
Table 3: Consumer-brand relationship forms of the research (Fournier, 1998) 
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Firstly, there are Arranged Marriages that have started by a third party introducing the brand 
to the consumer. For Tuuli, this was her grandmother nearly forcing her to commence taking 
vitamin D for long-term purposes. Perhaps due to the start of the relationship by a third party, 
Tuuli was not extremely committed to the brands and would also consume the product when 
remembered. However, since her grandmother plays such an important role in her life in 
terms of being “a health guru”, she was convinced to begin consumption of this product even 
if it was irregular. Regarding Sara, Lisa would recommend using magnesium and OTC iron 
tablets during the period, another brand relationship formed by the preference of a third party 
and thus resulted in an Arranged Marriage. 
 
Childhood Friendships to the consumers would resemble from the past self and provide com-
fort. These relationships would be infrequently engaged in, which Esa’s consumption of 
Aqualan L is a perfect example of. He would identify this consumption deriving from his 
childhood home, resembling him from the past, and being very infrequent, as he would pur-
chase the body lotion when his skin was absolutely in need of it, generally during winter. For 
Lisa, it would be same with Multitabs that she identified was used in her childhood as well. 
The usage was also rather infrequent, as she would usually purchase this brand for her chil-
dren. The usage of Multitabs along with memories of Aspirin and Disperin, though she would 
no longer use these brands due to stomach problems, could also be labeled as Kinships, rela-
tionships deriving from lineage ties. This relationship type also existed in Sara’s and Tuuli’s 
consumption of body lotions purchased from the pharmacy, in Tuuli’s situation Aqualan L as 
it would remind her of her mother and her cousin, who introduced the brand to her during her 
early years.  
 
Though no relationship of Dependence was found, Milla’s consumption of Burana much re-
minds of the Best Friend type. She shared very intimate feelings with this brand, as the brand 
would support her life value of ethical-awareness in not experimenting with animals that 
much and being domestic, as well as providing her feelings of safety and “home”. As she de-
scribed, the relationship was so strong due to there not being any negative experiences with 
the brand, thus Burana continuously providing positive feelings for her. However, there was 
no Dependence either due to Milla identifying that if the brand was out of stock, she could 
easily purchase another premium analgesic medication brand’s products, though this had nev-
er occurred.  
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The second strongest relationship type, Committed Partnerships, was found in Esa’s, Lisa’s, 
and Mika’s consumption. Esa would purchase Finrexin time after time, though identifying 
himself extremely price-conscious. As he described, Finrexin is a “partner of trust and com-
mitment” and the consumption derives from his childhood. Though it might have begun as a 
Kinship, implying that Finrexin was first bought by his mother, it had developed to a quite 
intense and voluntary relationship during time. Aqualan L could also be labeled as a Commit-
ted Partnership; however, it is categorized as a Kinship because Esa did not regard it as im-
portant as Finrexin. Similarly, Mika shared a Committed Partnership with Nasolin, a nasal 
spray that broke the rules of price-consciousness and followed long-term consumption. The 
relationship was so strong that Mika would continue the usage even when he was not suffer-
ing from a cold, almost one of Dependence. Finally, Lisa shared committed relationships with 
Calsorin D3 and a vitamin B brand, though after an Arranged Marriage of these brands being 
recommended by a doctor. Despite, in time she had developed such an intense relationship 
with these products that she would keep them with her other, daily medication and thus con-
sider them nearly the same level as prescription medicines. 
 
Marriage of Convenience existed in Lisa’s use of Losec and other heartburn brands after Pep-
cid Duo always being out of stock in pharmacies. Thus, the consumption was long-term, but 
lacked deliberate use and was more influenced by the environment, which evoked negative 
feelings in her as these products were not as effective as Pepcid Duo. The relationship, there-
fore, could also be labeled as an Enslavement, because she has to use these other brands due 
to the circumstances of needing relief, but not being able to purchase the brand of preference. 
This was also the situation with Panadol, which she told was not effective at all, but since she 
could not use acetylsalicylic acid or ibuprofen containing products, she would be forced to 
use this OTC painkiller. Again, this would evoke negative feelings in her because she would 
feel the consumption thus being nearly “purposeless”, the worst feeling she could experience 
with consumption of medication. On the other hand, consumption of Pepcid Duo would fol-
low an Avoidance-driven relationship, as by using this brand she would be desisting from the 
use of Nexium, an expensive, prescription-requiring heartburn brand. Mika experienced both 
a Marriage of Convenience and a Courtship with Tylenol, because he had taken it for alleviat-
ing reasons, but highly preferred the product and was interested in developing a long-term 
relationship with this brand. However, since it is not sold in Finland, this is not possible, 
which caused negative feelings and could further result Ibumax/Ibusal to be labeled as an En-
slavement.  
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One of the examples of an evolved brand relationship would be Sara’s use of Caffeine tablets. 
It started out as a Fling, which is a common way of Sara’s brand relationships to begin due to 
her impulsive and disloyal purchase behavior. Quickly after the intimate experiences she 
shared with the brand of it helping her through a painful breakup and simply providing aid in 
daily life, she started to grow attach to it, thus implying a Courtship. Following, Mika and 
Tuuli are both currently experiencing a Fling with Aco brand of skincare. They considerably 
like the brand and emphasize its great qualities, yet define that are already looking for switch-
ing to a new, better brand. They, therefore, are not searching for a committed relationship, but 
one of trying something new, which could be explained by their impulsive nature.  
 
Tuuli also shares a Casual Buddy type of relationship with a multivitamin brand called Multi-
tabs that she claimed to be Multivita during the interview, but was revealed to be Multitabs by 
the picture she provided. Tuuli told that her consumption is infrequent and that she does not 
actually believe in the brand helping her. Moreover, she is annoyed by the advertisements that 
to her do not represent authentic values. Mika shares the same thoughts regarding all vitamin 
brands and both of these consumers’ attachment towards the brands is rather low, as they 
would only consume the product if remembered.  Sara joins in with somewhat similar behav-
ior with her consumption of vitamins: she expects the product to balance her lifestyle and thus 
believes in it. With Esa, Voltaren could be categorized as a Casual Buddy since his belief and 
expectations towards the product are low, the usage infrequent, and experienced effect mini-
mal. 
 
The final relationship type easily identified and perhaps most commonly experienced by the 
interviewees is Friendships. These relationships are highly specialized, but contain high in-
terdependence and are situation-specific. They are enduring ones, as can be seen from Sara’s 
usage of the specific ice bag brand and Lisa’s use of a constipation medication called Laxo-
beron. Tuuli also shares this relationship with a gastrointestinal medicine called Vi-Siblin that 
she relies on in situations of stomach problems. Regarding Sara, the relationship may also be 
seen in her consumption of Ibusal/Ibumax and Bepanthen. Milla’s relationship with Ceralan 
can, moreover, be understood by labeling it as a Compartmentalized Friendship, because 
there is high interdependence and commitment, but it is not as involved as a Best Friend type 
of a relationship. Mika’s relationships with Ibumax/Ibusal also follows this relationship type, 
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since it is not extremely loyal but situation-specific. All of these relationships are character-
ized by easy entry and quitting. 
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Fournier (1998) introduces five attributes that characterize a strong Brand Relationship Quali-
ty. In this part, it seems reasonable to use a particular brand relationship as an example due to 
it being the strongest one and thus providing most insight regarding the theory. This relation-
ship is the one shared by Burana and Milla, which was defined as the Best Friend type in the 
above section. Though from the categorization, Dependence would be the most powerful one, 
no one admitted having such, which may be explained by the consumers not wanting to be-
come dependent on OTC medicines, or in fact with any medicines as it is not healthy.  
 
The first dimension Fournier described implies a strong brand relationship was Love and Pas-
sion, which was found in Milla’s case, but more in a form of fondness that had developed 
over time. Milla would carry Burana in her purse all the time, and if she did not have the 
product available, she would not feel comfortable. Neither would she feel pleasant using oth-
er, inexpensive medication, but rather Burana because it is a brand she is attached to. In addi-
tion, her perception of Burana solely follows positive attributes, as she uses such adjectives as 
“friendly”, “partner”, and “trustworthy” of this brand. Self-connection may also be seen here, 
when Milla depicts her values of purchasing domestics products and not supporting animal 
experiments. With Burana, she has reasoned herself that since it is such an old brand, it does 
not harm animals that much and therefore is more ethical. Moreover, Milla knows that Burana 
is manufactured in Finland, which brings her comfort of supporting domestic brands that is a 
value derived from her childhood and parents’ example. She also told how her parents had 
relied on Burana for a long time, indicating another self-connection. In particular, it is inter-
esting that Milla does not emphasize the strength or functional qualities of Burana, but rather 
prefers to talk about more abstract values. 
 
Interdependence is also present in Milla’s consumption. Though the usage is not so frequent, 
which regarding OTC analgesic drugs is justified since she does not use the medicine for any 
type of sickness, she has developed certain consumption rituals. As was described in her con-
sumption profile, she would prepare for a movie after work by assuring there was Burana 
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available due to knowing that the day would yield a terrible headache. In addition, she had 
developed a special dosage of taking only half of a tablet after learning from experience how 
strongly and long the product affects. Milla also experienced high levels of Intimacy with the 
brand, but not because of the product being superior due of its functional qualities, but rather 
the personal connections that she shared with the brand, resulting from long-term usage and 
experiences with the brand. She shared an experience very personal to her that had strength-
ened her trust towards Burana. This all has created her relationship extremely strong and re-
sistant towards competitors’ brands.  
 
The final attribute, Relationship Quality, is well seen in Milla’s explaining of: 
 
M: - such as Burana, probably they do those [animal tests] to some extent like every pharma-
ceutical company, but since it’s such an old medicine it does not have to be tested that much. 
 
 
In this part, Milla’s trust and relationship quality is best seen in, as she has explained and de-
veloped her own biases of the brand that are not based on facts but merely exist in a mental 
image. After all, she feels that the brand has her feelings in priority, is one of dependence, and 
will deliver what it promises rather than what she would fear, which would be uncontrollabil-
ity of her actions and acting against her life values. Hence, Fournier’s (1998) Brand Relation-
ship Quality may easily be seen in this specific relationship. 
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8 DISCUSSION 
 
The second final chapter will unify the empirical part and theory as well as suggest practical 
implications for the management. The most central themes and literature findings will be pre-
sented and the research questions answered. This chapter will include my own personal sug-
gestions regarding branding and the following strategic decisions. Theoretical framework and 
the case company are also examined from a critical point of view. Afterwards, limitations and 
suggestions for future research will be presented and the final chapter of this thesis contains 
conclusions in a form of introducing the future trends of the industry and how proper brand-
ing is a vital component of it. 
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The topic of the thesis addressed brand relationships between consumers and OTC brands as 
well as the corporate brand. The practical aim was to discover whether it would be suggested 
to utilize corporate brand in product marketing or not (Laforet & Saunders, 1994; Berens et 
al., 2005; Laforet, 2011). For this clear suggestion the answer is negative, because the corpo-
rate brand of Orion at present is not recognized enough to provide differentiation to a con-
sumer, except for very educated and involved individuals (Moss, 2007; Shamma & Hassan, 
2011).  
 
If, however, Orion was to commence a strong development of their corporate brand, empha-
sizing attributes that are important for the consumers such as trust, the quality of being Finn-
ish, and having old and ethical brands should be used. In addition, the corporate brand should 
be brought closer to an individual consumer in terms of marketing. Only after that would it be 
justified to be utilized in the product level. Currently, the corporate brand is simply too weak 
(Moss & Schuiling 2004; Moss, 2007) to work as a cue for the consumer in a market that still 
principally seems to be driven by price. The answer to the first part of the research question 
then is that consumers do not seem to maintain any particular relationships with the corporate 
brand of Orion, as they regard it too distant. Branded Identities is, therefore, the suggested 
corporate brand dominance strategy to use for now in product marketing (Laforet & Saunders, 
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1994; Nelson, 2002; Berens et al., 2005), which already seems to be the status quo in the in-
dustry. 
 
However, if the corporate brand were strengthened and afterwards utilized, it is suggested that 
it would not be applied to product lines that are not close to the corporate business strategy; 
manufacturing medical products (Berens et al., 2005; Laforet, 2011). With vitamins and cos-
metic brands, such as Multivita and Favora, the product brands should only be used because 
the corporate brand does not bring any extra value to the marketing, especially since the con-
sumers have very neutral thoughts towards it. If, however, a new OTC drug were brought to 
the market, Orion’s brand could be leveraged (Uggla, 2006), but to what kind of extent is an-
other chapter due to the weakness of it (Moss, 2007).  
 
What is interesting is that companies that traditionally have strongly exercised the branded 
identities strategy have recently begun to indicate signs of endorsed branding in their product 
marketing (Laforet & Saunders, 1994). This has clear benefits of cost effectiveness, easiness 
of leveraging brand extensions, and gaining awareness of the existing customers. In this situa-
tion, however, the companies are acting against the suggestion of only utilizing corporate 
brand when there is a fit between the product brand (Laforet & Saunders, 1994; Berens et al., 
2005; Laforet, 2011), and Laforet’s claim of the companies returning to practice mono brand-
ing strategy. 
 
Not using the corporate brand in the consumer level also brings certain benefits, since the 
corporate brand dominance strategy contains risks (Saunders & Fu, 1997). Namely, the risks 
may exist in one of the products failing and this mirroring to the other products. I did not find 
this in my empirical research. However, consumers did frequently emphasize that their trust 
towards a specific product was supported by “the product never having failed”. This was also 
the thought with the pharmacy, as some consumers depicted how they would trust the institu-
tion so vastly because they had never confronted negative, product-related experiences and in 
general were satisfied (Hess & Story, 2005). Thus, it is questionable whether the corporate 
brand should be avoided when marketing already powerful brands such as Burana and Aqua-
lan L because they simply do not need it and it could present significant risks. On the other 
hand, if Orion was to begin strong marketing of its corporate brand and executed the strategic 
choice of utilizing it in the product level, it could be applied to the strong brands’ marketing 
to leverage the associations of these products and their customers. Further on, the strong 
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product brands could act as “mini corporate brands” and their presence utilized in novel, simi-
lar products’ marketing to gain benefits. 
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When considering the actual brand relationships, it is evident that consumers maintain strong 
feelings among with private and emotional histories with even such rational-driven products 
as medicines that operate in a market suffering from intense price competition (Moss, 2007; 
Moss, 2008; Veloutsou & Panigyrakis, 2010). The example by Milla and Burana well authen-
ticated Fournier’s (1998) theory of brand partner quality, as did the consumers’ relationships 
with OTC brands the typology of relationships. However, certain relationship types as such as 
Dependencies, Secret Affairs and Enmities were left out, but this was explained by reason in 
the last chapter.  
 
What becomes fascinating, however, when looking at the theory is the formation of trust. 
Blackett and Harrison (2001) explained pharmaceutical products to demand especially high 
trust from the consumers. I discovered that trust was something the consumers regarded im-
portant but had developed by the power of the culture and environment. It was not the manu-
facturer that to most brought comfort, excluding Milla, but the spirit and general thinking 
among the nation in terms of “we live in a safe place, where we cannot be harmed”. This 
would drive the consumers to use expired medicines, purchase brands they had never heard 
of, use other people’s prescription products, and even consume medicines that are not sold in 
Finland. In this sense, various studies’ (e.g. Usunier & Lee, 2000; Sanyal & Datta, 2011; 
Kauppinen-Räisänen et al., 2012) claim of the country of origin driving the purchase decision 
was not found here, which I reckon was because this attribute is not utilized in the marketing 
as efficiently as possible. All in all, the consumers did not regard medicines as a “scary” 
product, though they would prefer to avoid consumption.  
 
I detected several reasons driving consumption of OTC products in my empirical part. The 
most significant, regarding the methodology and theory (e.g. Fournier, 1998), was that con-
sumers exercise their life values when consuming even the most dull products, OTC medi-
cines. To a consumer, selecting an analgesic medication brand is much more than solely the 
pharmacist convincing them to purchase a product they would be completely clueless about. It 
  
 87 
is about the consumer’s feelings, memories, people around, culture, and habits. By purchasing 
a vitamin product the consumer could develop feelings of caring for her adult children’s 
health, a life value shared by the whole family. Moreover, the product could act as a savior for 
the consumer. Taking analgesic drugs would enable the consumer to enjoy his vacation like a 
healthy person though he was suffering from a severe flu. Despite a terrible personal crisis, 
the consumer would be able to perform needed acts; for example, take the exam in the follow-
ing morning of a bad breakup. Or by using medicines, the consumer would be able to lead a 
“normal” person’s life and compete even in the national level in sports despite suffering from 
asthma. This all indicates that though consumers would have some questions with OTC drugs 
in terms of addictions and pharmaceutical companies in whether their actions were always 
done in favor of the end user’s, the consumers regard the products safe, positive, and reliable, 
sometimes even as heroes of their lives. 
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The study validated Moss and Schuiling’s (2004) claim that pharmaceutical companies are 
not exercising proper brand naming strategies, especially in utilizing the corporate brand 
name in product brand marketing. This would provide the associations of the corporation to 
the product level and could be used more extensively in the future, if the corporate brand was 
strengthened. I also found correct what Moss and Schuiling wrote about descriptive names of 
medical brands, which are based on the compound or the disease and the most common way 
of naming, to lead to consumer confusion. Moreover, the consumers would frequently men-
tion Burana as a synonym for painkiller, again validating Moss and Schuiling’s statement of 
short and unique names working the best.  
 
The consumers I interviewed were confused whether it was Ibusal or Ibumax, Multivita or 
Multitabs they were using, and would not even recall the vitamin D or B brands consumed 
because these would have a name of “vitamin D” or such, which for the consumer is too un-
recognizable. This is something that should be paid attention to, especially since Laforet 
(2011) described how proper brand names may have a significant impact on consumer pur-
chase behavior, and as my empirical part proved, the consumers would purchase either one of 
the similar named products due to not noticing any differences. This stresses the importance 
of the brand name that in fact is one of the most central components of efficient brand posi-
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tioning. Moreover, utilizing corporate branding efficiently and properly may also be exercised 
here, since Ladha (2007) suggests that the limited lifespan of pharmaceutical products could 
be stimulated by attaching the corporate name more strongly to product brand names. 
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Hess and Story (2005) defined that consumer commitment is  a sum of satisfaction and trust, 
the latter which was formed by personal and functional connections. Though some consumer 
would experience both trust and satisfaction, commitment would not be developed because of 
their impulsive nature and willingness to experiment with new products. This relationship 
type in Fournier’s (1998) typology reminds of a Fling, and I discovered two of these types of 
consumers in my research. Despite, these consumers also had certain brands that they would 
remain with and not try new ones. In my experience, this type of behavior cannot be under-
stood by simply evaluating functional and personal connection let alone satisfaction, but it is 
something more complex that is developed over time and affected by certain people in the 
consumers’ lives. However, I discovered that consumers build their relationships mostly 
based on either personal or functional connections, and though ones including personal con-
nections seem to be the strongest (Milla and Burana), functional connections also play a key 
role and can lead to a strong relationship (Milla and Ceralan). It is also worth mentioning that 
as Papista and Dimitriadis (2012) found, strong relationships are not necessarily ones engaged 
in everyday.  
 
Trust is also affected by the purchase environment. The consumers described how buying the 
OTC products from a pharmacy creates feelings of safety. On the other hand, the pharmacy 
was seen a purchase environment as rational as the products and the consumers did not think 
that the environment evoked purchase desires. By branding the products better, for example, 
focusing on the displays and brand communication already in the point of sale situation, this 
problem could be overcome. Perhaps a suggestion is to move further down to the same tech-
niques strong FMCG brands utilize, such as efficient placement planning and brand name 
communication. Moreover, if OTC products in the future were available in retail stores, this 
would ease the transmission from pharmacies, because the consumers would easily identify 
the products they had bought from pharmacies.  
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Authenticity (Malär et al., 2011) was discovered important for the consumer in terms of also 
OTC brands, especially in advertising. The consumers expounded Orion’s corporate brand 
advertisement to be something that first irritated them, because of the hidden means of taking 
advantage of the delicate issue of the War. Moreover, they would see pharmaceutical adver-
tising as something that did not speak to them, because the methods of affecting consumer 
emotions were wrong and would at the end simply annoy. This was the situation in using over 
appropriate presentation of only the functional product attributes or humor in the product 
marketing, which consumers found tacky and fake. Originality, on the other hand, was some-
thing they would prefer along with stressing the quality of being Finnish.  
 
In terms of advertising, some academic studies (e.g. Blackett & Harrison, 2001; Friedman & 
Gould, 2007) have identified direct-to-consumer advertising (DTCA) the rising trend and key 
for differentiation in the pharmaceutical business. According to my empirical part, it would 
work since the consumers indeed differ in terms of what drives their consumption of medi-
cines. Digital marketing would offer methods for DTCA through blog co-operation and social 
media. Nevertheless, according to Friedman and Gould, this is not properly understood, and 
consumers experience the marketing rather negatively since benefits and risks of the adver-
tised products are not communicated well enough. If this were duly conducted, affecting the 
consumers personally would be an efficient method (DeLorme et al., 2010) of also emotional 
branding and bringing the brand closer to the consumer, but of course this presents certain 
challenges due to the Finnish legislation.  
 
It should also be noted that if the corporate brand dominance strategy is desired to be brought 
to the individual brand level, advertising the logo simply along with brand commercials is not 
sufficient because this does not evoke salience in the consumers’ minds. Firstly, the company 
would need to begin quite an extensive corporate brand campaign to have something for the 
consumers to clasp, because simply mentioning a logo in the advertisement is not powerful 
enough for the consumer to remember after being exposed to dozens of similar types of ad-
vertisements during the day (Moss, 2007). 
 
Malär et al (2011) described how consumers would either be attracted to advertisements ap-
pealing to consumers’ real selves or the ideal selves. From the empirical part, it may be seen 
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that some consumers would prefer appealing to the ideal self; for example, the healthy person 
they wanted to be by using vitamins. On the other hand, Milla’s example revealed that she 
was attracted to Burana because the brand served her extremely personal life values, thus also 
appealing to the real self. Milla’s example, moreover, verified Malär et al.’s claim that actual 
self-congruence led to higher emotional brand attachment. Indeed, she expressed herself by 
consuming Burana that supported the ethical and domestic values. 
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Though Orion is somewhat distant and unknown for consumers, its advantages are that there 
are no negative associations, as there are with, for example, Nestlé. Therefore, concentrating 
on strengthening the corporate brand so that it would become meaningful to the consumer 
provides extensive opportunities. In fact, there are signs that the large pioneers of consumer 
behavior, FMCG companies, are now altering their strategies towards applying corporate 
brand in product marketing. Various academic studies have further proven the relevance of 
branding in the medical field (Blackett & Harrison, 2001; Kauppinen-Räisänen et al., 2004; 
Moss & Schuiling, 2004; Schuiling & Moss, 2004; Moss, 2007). Consequent of corporate 
branding, brand extensions might be developed to benefit from the associations and existing 
consumers. In addition, it is interesting that some consumers regarded the pharmaceutical 
business not that innocent, but regarding Orion they did not hold these thoughts.  
 
What could be exercised in practice would be to, first of all, alter the slogan of the corporate 
brand that the consumers did not even remember as it is not differentiating enough to portray 
the core benefits of the company. Here such adjectives as trustable, high quality, and the qual-
ity of being Finnish that lie in the core of the whole business should be utilized. Though the 
products were not manufactured in Finland, this does not hinder because the company is Finn-
ish and holds long traditions in the culture, therefore differentiating it from others. As con-
sumers expressed, if there were two products priced the same, they would choose the Finnish 
one. Moreover, regarding their favorite products they were highly price tolerant. Being Finn-
ish and products belonging to a Finnish company could thus be more efficiently communicat-
ed, in particularly since Pecotich and Ward (2007) found that consumers employ the compa-
ny’s quality of being domestic as a risk reduction cue. Indeed, some of the consumers were 
not even sure Orion is still a domestic company.  
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Stressing the quality of being Finnish, in particular, could be exercised with known brands 
such as Burana and Aqualan L, which are both manufactured in Finland, in order to transfer 
this association. As a result, customers and profits would be leveraged to Orion’s other prod-
ucts as well. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Practicing more efficient advertising by appealing to consumer emotions should also be a 
method to consider. Instead of indicating body parts where the analgesic drug affects, the ad-
vertisements should include softer and more personal aspects to the consumer. When looking 
at American pharmaceutical commercials, this is a method widely used in appealing to the 
values of the target group instead of only presenting the functional benefits. However, the 
Finnish legislation ought to be kept in mind here as well as transparency and utilitarian image. 
 
The management also needs to note that even though drugs are functional products instead of 
“candy” or something to be enjoyed, the brands still represent emotional memories of people 
and places deriving from as far as the consumer’s childhood. These consumers do not simply 
rely on price when selecting products, neither is the product purchased because it would be 
Aqualan L 
Orion 
Core value:  
The quality of  
being Finnish 
Brand  
extension 
Associations 
Associations 
Associations 
Completely 
new brand 
 
Burana 
Chart 3: Utilizing the new core value in brand hierarchy 
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the most efficient one. Even OTC medical brands can contain strong feelings and act as part-
ners in daily routines, or as means for saving a person’s day. Focusing on these, differentiat-
ing attributes from other consumer products is a method of building consumer attachment and 
should, therefore, be stressed in marketing. 
 
The final managerial suggestion is to comprehensively consider entering the retail market. 
Especially in the future, if OTC painkillers were allowed to be sold in grocery stores, this is 
something to be thought of. After all, the company should always maintain the consumers’ 
preferences as top priority, especially due to the altering role and increasing empowerment of 
an individual customer. If purchase desires are to be formed and the consumers to be provided 
with the feeling of being in control, this is a method worth considering. In the empirical part it 
was discovered that nothing negative could come out of this in the minds of consumers, if the 
brands were ones sold in pharmacies as well, and products the type that contain no large risks. 
Entering the retail channel above all would require efficient corporate branding that should 
immediately be started, because in the future there could be an opportunity to market such 
products as “Orion’s OTC pain medicine” in grocery stores. 
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The research includes certain limitations. The purpose of neither this study nor the interview-
ee group is to present any simple and universal truths about the subject, but rather to explain 
how the consumers experience consumption of OTC medicines and brands. Consequently, the 
consumers did not distinguish prescription medication from OTC products all the time, but 
would discuss medicines in general. The only time some of them would stress the difference 
was when asked about what actually separates these two from each other. For this reason, the 
empirical part may at times also discuss the role of prescription medication.   
 
Moreover, though existential-phenomenological methodology suggests not to compare the 
consumers’ experiences with each other, but merely describe them as idiographic cases, I 
have analyzed these differences as well since it seems proper when investigating such a new 
phenomenon and one that is so complex. The limitation with brand relationship typology is 
that it is based on my own analysis and many of the relationships could have belonged to two 
or more groups, so I have chosen the one that matches the best. The final limitation would lie 
in the methodology as it investigates consumer narratives, which are not questioned or asked 
what causes them. The experiences are rather subjective views that may be biased. 
 
It would be interesting to concentrate on a particular relationship type of Fournier’s (1998) 
typology and investigate it in the pharmaceutical field. Dependencies would be this type of 
relationship to study as well as the strong relationship types, such as Best Friends. In addition, 
the participant group could include various types of consumers to see if this affected, though 
phenomenology stresses that demographic attributes do not affect the outcome of the research 
as all consumers share own, differing experiences and stories with brands. However, this type 
of research could be conducted in a different culture to see if the cultural issues indeed affect 
trust formation. Finally, a study where the difference between an industry including strong 
brand relationships and pharmaceutical business could be conducted. I would also suggest 
researching the effect on consumer behavior of OTC products being sold in the retail envi-
ronment. Properly speaking, there are multiple interesting topics emerging from the thesis that 
would deserve to be researched. 
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9 CONCLUSIONS 
 
 
From the empirical part it can be seen that there is a need for better brand building in corpo-
rate level as well as product level. This offers a new business strategy to pharmaceutical com-
panies that have trouble in advancing new blockbuster medicines or with traditional market-
ing channels such as affecting doctors or pharmacies by personal selling. The pharmaceutical 
industry indeed is experiencing certain quite extensive changes as legislation and regulations 
are tightening and new geographical areas offering opportunities for manufacturing bargain 
remedies in masses.  Focusing solely on R&D and sales is an old-fashioned method and the 
companies need to maintain the pace of the evolving consumer behavior. Moreover, the OTC 
market is expected to expand in the future and thus offers significant opportunities for the 
companies in terms of also concentrating on branding. 
 
Nevertheless, branding of products is not the sole rising trend to eclipse the above changes. 
Foundations of specific diseases such as breast cancer have commenced to brand conditions 
in order to spread knowledge of the sicknesses and fundraise research (Angelmar et al., 2007). 
For pharmaceutical companies this offers an opportunity to be associated positively in the 
minds of consumers. However, one could question whether this type of behavior is ethical, or 
even if product branding is ethical in terms of medication, because the aim is to develop high-
er price tolerance and benefit the company. To diminish the ethical concerns, the companies 
thus should invest in building the utilitarian image and stressing that the actions are conducted 
in order to aid the patients and consumers instead of only providing financial benefit for the 
company. Here, the ability to appeal to consumers’ emotions is in particular needed. Hence, 
practicing it efficiently should already be started, in addition to building a corporate brand 
that indicates concern for the consumers’ needs. 
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11 APPENDICES 
 
 
Picture 2: The corporate brand advertisement of Orion 
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Table 2: Background data of the interviewees 
 
 
 Mika Sara Lisa Tuuli Esa Milla 
Gender M F F F M F 
Age 24 21 52 25 25 25 
Hometown Eastern Finland Capital area Capital area Helsinki Helsinki Helsinki 
 
Occupation,  
lifestyle,  
life values 
 
Postgraduate of two 
degrees. 
Has held two jobs 
while studying. 
Definition: Busy, 
young, and urban 
male consumer.  
Regards succeeding 
and hedonistic values 
important. Consump-
tion driven only by 
need and prince-
consciousness. 
 
Student, works occasion-
ally in a fashion retail 
shop. Former athlete, 
competed in the interna-
tional levels in martial 
arts. 
Definition: Rather  
recently moved out of the 
childhood home, young, 
athletic, and likes to  
party. Consumption driv-
en by prices, but also 
domestic products and 
ethical issues important. 
 
Retired for health  
reasons, degree in  
economics. 
Definition: Permanently 
sick, held a long career 
in career counseling. 
Enjoys softer values in 
life such as looking 
after her children and 
maintaining good 
health. 
 
Communications con-
sultant, degree in busi-
ness. 
Definition: At the  
beginning of her  
ambitious career, busy 
female consumer. 
Steady earnings, re-
gards also softer values 
important such as 
spending time in her 
summer cabin, and 
ecological matters. 
 
Officer in the military, 
degree in military 
sciences. Actively 
practices various kinds 
of sports.   
Definition: Opinionat-
ed, initiative. Wants to 
make decision by him-
self and regards indi-
vidualistic values im-
portant. Highly rational 
and logical thinking as 
well as “all or nothing” 
philosophy. 
 
Postgraduate, works 
part-time in a manufac-
turing company. 
Definition: Finishing her 
degree, and about to 
enter working life.  
Regards ethical values 
important, is a vegetarian 
and stresses animal 
rights. Is not as price-
conscious. Initiative and 
information seeking way 
of consuming. Values 
familiarity and safety. 
 
Marital status 
 
Unmarried, lives with 
his sister 
 
Unmarried, shares a stu-
dent apartment with 2 
other students 
 
Married,  
2 children 
 
Common-law  
marriage 
 
Unmarried, lives alone 
 
Unmarried, lives alone 
 
Length of the 
interview 
 
1) 44 
2) 26 
70 
 
 
87 
 
77 
 
81 
 
1) 33 
2) 42 
75 
 
 
1) 77 
2) 9 
86 
 
Brands consumed 
and discussed 
 
Nasolin, Ibus-
al/Ibumax, Unikuu, 
Rennie, Burana, 
Cough medicine, 
Aco, vitamin D 
 
Ibusal/Ibumax, Imodium, 
Multivita, Nasolin, Ice 
bags, Nasal spray brands, 
Burana, Multivitamins, 
vitamin D 
 
Aspirin, Pepcid Duo, 
Calsorin D3, Burana, 
Multitabs, Laxoberon, 
Panadol, lotions 
 
Bepanthen,  
Multivita/Multitabs, Vi-
Siblin, Aqualan L, 
Ibusal 
 
Finrexin,  
Ibusal/Ibumax, Burana, 
Aqualan L, Duact 
 
Burana, Ceralan, Ibumax  
